|
(Mark One)
|
|
|
☑
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
|
September 30, 2019
|
OR
|
||
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from to
|
Delaware
|
|
94-3156479
|
|
(State or Other Jurisdiction of
|
|
(I.R.S. Employer
|
|
Incorporation or Organization)
|
|
Identification No.)
|
|
|
|
|
|
1 Wayside Road
|
|
01803
|
|
Burlington,
|
Massachusetts
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
Common stock, $0.001 par value
|
NUAN
|
Nasdaq Stock Market LLC
|
|
Large accelerated filer
|
þ
|
|
Accelerated filer
|
¨
|
Smaller reporting company
|
☐
|
|
Non-accelerated filer
|
¨
|
|
Emerging growth company
|
☐
|
|
|
|
|
|
Page
|
PART I
|
||
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
||
PART II
|
||
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
|
||
PART III
|
||
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
|
||
PART IV
|
||
Item 15.
|
•
|
Transitioning to cloud-based solutions in Healthcare. We are transitioning our Healthcare solutions to the cloud, enabling us to shift our revenue mix to a more subscription-based, higher-value recurring model. We’ve established Nuance as a cloud platform in all our solution areas within Healthcare. During the year, we made significant progress migrating incremental Dragon Medical on-premise customers to the cloud with Dragon Medical One (DMO). We launched the new cloud solutions, including PowerScribe One for our radiology base, and CDE One for clinical documentation improvement programs. We have created a go-to-market approach that aligns sales compensation to our cloud models, and have enabled our channel to sell Dragon Medical cloud. We also launched new Dragon Medical cloud offerings in certain international markets, including Canada, United Kingdom and Australia.
|
•
|
Expanding our Intelligent Engagement portfolio in Enterprise, with a focus on cloud. While we maintain leadership in Voice IVR offerings, we are increasing our focus on Intelligent Engagement growth opportunies, which includes live and virtual engagement offerings, as well as Security and Biometrics. We recently launched Nuance Gatekeeper, a new cloud-native voice biometrics and authentication solution. We expanded the cloud-native stack with the roll-out of Intelligent Engagement Services for Conversational AI, Messaging, and Agent AI. These solutions offer customers more flexible integration with third-party systems and the ability to deploy across hosted, public, or private cloud. It gives large enterprises more options for deployment while making Nuance technology available to smaller organizations via the cloud model.
|
•
|
Expanding our go-to-market presence. We are increasing sales coverage in new markets and developing new solutions to increase our customer lifetime value. In Healthcare, we are pursuing under-served markets, including community hospitals, ambulatory clinics, and surgery centers. We also are launching new solutions for specialty areas such as pediatrics, the emergency department, and surgical, as well as increasing our federal and other government customer offerings. In Enterprise, we are expanding our Intelligent Engagement solutions into our existing IVR customer base and delivering new rapid AI development tools that will allow us to increase our penetration into mid-market accounts.
|
•
|
Expanding internationally. In Healthcare, we continue to expand our international presence in the UK, France, DACH region, Nordics, Australia, and Canada with a growing direct sales force and new offerings. In Enterprise, we continue to expand our international presence in the UK, France, Spain, Germany, Italy, Japan, Australia, New Zealand, Mexico, Brazil, Argentina, and Canada with expanded Intelligent Engagement offerings and sales focus.
|
•
|
Accelerating our innovation activities. We are accelerating investment in research and development, with a focus on new AI products, including our development of ambient clinical intelligence (“ACI”), sub-specialty solutions, and the AI Marketplace for Diagnostic Imaging in Healthcare. In Enterprise, we launched Nuance Gatekeeper, a new cloud-native voice biometrics solution for authentication and fraud prevention across voice and digital channels and rapid AI development tools for large and mid-market enterprises. In addition, we launched Nuance Lightning Engine, within our Security Suite, which combines NLU with voice biometrics to personalize responses and validate individuals faster than before.
|
•
|
Growing through targeted acquisitions and strategic investments. While organic growth is our priority, we also expect to selectively pursue acquisitions and investments in businesses and technologies that advance the strategies described above.
|
•
|
Dragon Medical One: Our cloud-based speech solution provides a consistent and personalized clinical documentation experience across solutions, platforms, and devices, regardless of physical location. Dragon Medical One allows clinicians to use their voice to securely capture the patient story and control applications more naturally and efficiently - anywhere, anytime. Dragon Medical One is HITRUST CSF-certified and uses a secure desktop app to keep data private and protected. It helps increase productivity and offers more flexibility and personalization while establishing a firm foundation for organizations to take advantage of new and future innovations, including virtual assistants and ambient clinical intelligence (“ACI”).
|
•
|
Computer-Assisted Physician Documentation (“CAPD”): Backed by AI, our solutions give physicians in-workflow guidance to drive better data outcomes across the continuum of care. Our CAPD solutions apply workflow and knowledge automation, proven clinical strategies and point-of-care advice to capture complete and accurate documentation while improving productivity and satisfaction. We make it easier to add specificity to existing diagnoses, discover evidence of undocumented diagnoses and support various specialties and care settings. Details are extracted from patient narratives for fast and accurate translation into discrete data, while coding assistance helps capture professional charges, improve quality and reduce retrospective queries.
|
•
|
Clinical Documentation Improvement (“CDI”) and Coding: Our comprehensive portfolio of cloud-based technologies is designed to help increase the productivity and effectiveness of CDI teams. Our clinically focused program and services deliver documentation guidance, AI-powered encounter prioritization, workflow management, denials support and analytics to drive better documentation across the care continuum. Designed with scale and reliability in mind, these solutions require lower installation, deployment and maintenance costs and are hosted on Microsoft Azure, a HITRUST CSF-certified infrastructure to support privacy, security and compliance. We provide real-time insights that promote a performance-driven program, allow peer comparisons and identify opportunities for improvement. Our Coding solutions offer cloud-based, enterprise-wide products and services that are designed to improve coder productivity and maintain the highest levels of accuracy and compliance. These solutions effectively manage and monitor the types of compliance coding challenges that can put a health system at risk for delayed and reduced reimbursement. We help manage the workflow by bringing together the tools needed to provide better visibility into key coding performance indicators. Coder productivity can be enhanced by enabling a more complete and accurate review of both inpatient and outpatient encounters that are associated with facility and professional service fees.
|
•
|
Diagnostic Solutions: Our solutions continuously improve the efficiency and effectiveness of the radiologists’ work to improve clinical and financial outcomes across the continuum of care. Driving both speed and precision in how radiology is applied to patient care to maximize reimbursement, we reduce duplications and errors and alleviate burnout. Using AI, we help automate time-consuming, non-value-added tasks, freeing radiologists to perform more important tasks. By focusing more on integrating patients’ clinical and imaging information and collaborating better with peers, we help radiologists uplift their role within the care team.
|
•
|
Transcriptions Solutions: These solutions offer cloud-based transcription capabilities for clinical documentation that use background speech recognition to increase Medical Language Specialists’ productivity and reduce costs. Helping organizations simplify the documentation process by offering users an automated and flexible workflow with options designed to meet a facility’s specific needs, our solutions and services offer fast, accurate, and usable documentation with more seamless and fully automated processes that can identify discrete information and securely upload data directly into the electronic health record (“EHR”). Clinicians using EHRs can accurately document entire patient encounters using a mobile device or their standard dictation methods.
|
•
|
IVR Voice Solutions: These solutions add automated customer service to phone calls into a contact center. They are integrated with interactive voice response ("IVR") systems provided to the customer by us or by a wide range of third-party IVR and contact center vendors, who often resell our IVR Voice Solutions. Our solutions in this category include ASR, TTS, NLU and dialog engines, which are sold as perpetual licenses with maintenance and support ("M&S"), or volume-based transactional pricing. We also offer a cloud hosted IVR and voice automation platform which is largely sold direct through multi-year agreements with volume-based transactional pricing and associated professional services.
|
•
|
Intelligent Engagement Solutions: We have an open, modular cloud platform that provides enterprises with the ability to implement virtual- and live-engagement across nearly all digital voice and text channels. The platform supports virtual assistant, live engagement and proactive outbound services, using our conversational AI and engagement AI capabilities. Our intelligent engagement cloud is sold both direct and through partners, and are largely multi-year agreements with volume-based transactional pricing and associated professional services.
|
•
|
Security & Biometrics Solutions: These solutions enable organizations to automate the identification & verification (ID&V) of their customers using voice, face or behavioral biometrics, replacing time consuming security questions with either a simple phase - “At Big Bank my voice is my password” or simply by having the system listen to the conversation between the customer and agent. The system also can detect potential fraud using voice biometrics in real time or in batch, providing enterprises with an effective way of preventing fraud. We license this solution via perpetual M&S, on-premise transactional and cloud transactional models.
|
•
|
Specialized Professional Services. Our superior technology, when coupled with the high quality and domain knowledge of our professional services organization, allows our customers and partners to place a high degree of confidence and trust in our ability to deliver results. We support our customers in designing and building powerful innovative solutions that specifically address their needs and requirements.
|
•
|
International Coverage. The international reach of our solutions and technologies is due to the broad language coverage of our offerings, including our ASR and NLU solutions, which provide recognition for approximately 90 languages and dialects and natural-sounding synthesized speech in over 160 voices, and support a broad range of hardware platforms and operating systems.
|
•
|
Technological Superiority. We have deep domain expertise and our conversational AI technologies, applications and solutions are often recognized as the most innovative and proficient in their respective categories. Our ASR and NLU solutions have industry-leading recognition accuracy and provide a natural, voice-enabled interaction with systems, devices and applications. Technology publications, analyst research and independent benchmarks have consistently indicated that our solutions and technologies rank at or above performance levels of alternative solutions.
|
•
|
Broad Distribution Channels. Our ability to address the needs of specific markets, such as financial, law, healthcare and government, and to introduce new solutions and technologies quickly and effectively is provided by our direct sales force, our extensive global network of resellers, comprising system integrators, independent software vendors, value-added resellers, hardware vendors, telecommunications carriers and distributors, and our e-commerce website.
|
•
|
volume, timing and fulfillment of customer orders and receipt of royalty reports;
|
•
|
fluctuating sales by our channel partners to their customers;
|
•
|
customers delaying their purchasing decisions in anticipation of new versions of our products;
|
•
|
contractual counterparties failing to meet their contractual commitments to us;
|
•
|
introduction of new products by us or our competitors;
|
•
|
cybersecurity or data breaches;
|
•
|
seasonality in purchasing patterns of our customers;
|
•
|
reduction in the prices of our products in response to competition, market conditions or contractual obligations;
|
•
|
returns and allowance charges in excess of accrued amounts;
|
•
|
timing of significant marketing and sales promotions;
|
•
|
impairment of goodwill or intangible assets;
|
•
|
the pace of the transition to an on-demand and transactional revenue model;
|
•
|
delayed realization of synergies resulting from our acquisitions;
|
•
|
accounts receivable that are not collectible and write-offs of excess or obsolete inventory;
|
•
|
increased expenditures incurred pursuing new product or market opportunities;
|
•
|
higher than anticipated costs related to fixed-price contracts with our customers;
|
•
|
change in costs due to regulatory or trade restrictions;
|
•
|
expenses incurred in litigation matters, whether initiated by us or brought by third parties against us, and settlements or judgments we are required to pay in connection with disputes; and
|
•
|
general economic trends as they affect the customer bases into which we sell.
|
•
|
adverse political and economic conditions, or changes to such conditions, in a specific region or country;
|
•
|
trade protection measures, including tariffs and import/export controls, imposed by the United States and/or by other countries or regional authorities such as Canada or the European Union;
|
•
|
the impact on local and global economies of the United Kingdom leaving the European Union;
|
•
|
changes in foreign currency exchange rates or the lack of ability to hedge certain foreign currencies;
|
•
|
compliance with laws and regulations in many countries and any subsequent changes in such laws and regulations;
|
•
|
geopolitical turmoil, including terrorism and war;
|
•
|
changing data privacy regulations and customer requirements to locate data centers in certain jurisdictions;
|
•
|
evolving restrictions on cross-border investment, including recent enhancements to the oversight by the Committee on Foreign Investment in the United States pursuant to the Foreign Investment Risk Preview Modernization Act;
|
•
|
changes in applicable tax laws;
|
•
|
difficulties in staffing and managing operations in multiple locations in many countries;
|
•
|
longer payment cycles of foreign customers and timing of collections in foreign jurisdictions; and
|
•
|
less effective protection of intellectual property outside the United States.
|
•
|
loss of revenue resulting from the operational disruption;
|
•
|
loss of revenue or increased bad debt expense due to the inability to invoice properly or to customer dissatisfaction resulting in collection issues;
|
•
|
loss of revenue due to loss of customers;
|
•
|
material remediation costs to restore systems;
|
•
|
material investments in new or enhanced systems in order to enhance our information security posture;
|
•
|
cost of incentives offered to customers to restore confidence and maintain business relationships;
|
•
|
reputational damage resulting in the failure to retain or attract customers;
|
•
|
costs associated with potential litigation or governmental investigations;
|
•
|
costs associated with any required notices of a data breach;
|
•
|
costs associated with the potential loss of critical business data; and
|
•
|
other consequences of which we are not currently aware but will discover through the remediation process.
|
•
|
cause our customers to lose confidence in our solutions;
|
•
|
harm our reputation;
|
•
|
expose us to litigation, regulatory investigations and to resulting liabilities including reimbursement of customer costs, damages penalties or fines imposed by regulatory agencies; and
|
•
|
require us to incur significant expenses for remediation.
|
•
|
difficulty in transitioning and integrating the operations and personnel of the acquired businesses;
|
•
|
difficulty in separating the operations, personnel and systems of divested businesses:
|
•
|
potential negative impact on our profitability as a result of losses that may result from a divestiture, including the loss of sales and operating income or decrease in cash flows;
|
•
|
retained exposure on financial guarantee leases, real estate and other contractual, employment, pension and severance obligations of divested business, and potential liabilities that may arise under law as a result of the disposition or the subsequent failure of an acquirer;
|
•
|
potential disruption of our ongoing business and distraction of management;
|
•
|
difficulty in incorporating acquired products and technologies into our products and technologies;
|
•
|
potential difficulties in completing projects associated with in-process research and development;
|
•
|
unanticipated expenses and delays in completing acquired development projects and technology integration and upgrades;
|
•
|
challenges associated with managing additional, geographically remote businesses;
|
•
|
impairment of relationships with partners and customers;
|
•
|
assumption of unknown material liabilities of acquired companies;
|
•
|
the accuracy of revenue and bookings projections of acquired companies;
|
•
|
customers delaying purchases of our products pending resolution of product integration between our existing and our newly acquired products;
|
•
|
entering markets or types of businesses in which we have limited experience; and
|
•
|
potential loss of key employees of the acquired business or loss of key employees of a divested business.
|
•
|
costs incurred to integrate the operations of businesses we acquire, such as transitional employee expenses and employee retention, redeployment or relocation expenses;
|
•
|
impairment of goodwill or intangible assets;
|
•
|
amortization of intangible assets acquired;
|
•
|
a reduction in the useful lives of intangible assets acquired;
|
•
|
identification of or changes to assumed contingent liabilities, both income tax and non-income tax related, after our final determination of the amounts for these contingencies or the conclusion of the measurement period (generally up to one year from the acquisition date), whichever comes first;
|
•
|
charges to our operating results to eliminate certain duplicative pre-merger activities, to restructure our operations or to reduce our cost structure;
|
•
|
charges to our operating results arising from expenses incurred to effect the acquisition; and
|
•
|
charges to our operating results due to the expensing of stock awards assumed in acquisitions.
|
•
|
significant adjustments to our multi-year operating plans, in connection with our ongoing portfolio review;
|
•
|
changes in our organization or management reporting structure that could result in additional reporting units, which may require alternative methods of estimating fair values or greater disaggregation or aggregation in our analysis by reporting unit;
|
•
|
significant under performance relative to historical or projected future operating results;
|
•
|
significant changes in the manner of or use of the acquired assets or the strategy for our overall business;
|
•
|
significant negative industry or economic trends;
|
•
|
significant decline in our stock price for a sustained period; and
|
•
|
our market capitalization declining to below net book value.
|
•
|
projected levels of taxable income;
|
•
|
pre-tax income being lower than anticipated in countries with lower statutory rates or higher than anticipated in countries with higher statutory rates;
|
•
|
increases or decreases to valuation allowances recorded against deferred tax assets;
|
•
|
tax audits conducted and settled by various tax authorities;
|
•
|
adjustments to income taxes upon finalization of income tax returns;
|
•
|
the ability to claim foreign tax credits;
|
•
|
the repatriation of non-U.S. earnings for which we have not previously provided for income taxes; and
|
•
|
changes in tax laws and their interpretations in countries in which we are subject to taxation.
|
•
|
incur additional debt or issue guarantees;
|
•
|
create liens;
|
•
|
make certain investments;
|
•
|
enter into transactions with our affiliates;
|
•
|
sell certain assets;
|
•
|
repurchase capital stock or make other restricted payments;
|
•
|
declare or pay dividends or make other distributions to stockholders; and
|
•
|
merge or consolidate with any entity.
|
•
|
require us to use a large portion of our cash flow to pay principal and interest on debt, including the convertible debentures and the credit facility, which will reduce the availability of our cash flow to fund working capital, capital expenditures, acquisitions, research and development, exploit business opportunities, and undertake other business activities;
|
•
|
place us at a competitive disadvantage compared to our competitors that have less debt; and
|
•
|
limit, along with the financial and other restrictive covenants related to our debt, our ability to borrow additional funds, dispose of assets or pay cash dividends.
|
Item 1B.
|
Unresolved Staff Comments
|
Item 2.
|
Properties
|
Item 3.
|
Legal Proceedings
|
Item 4.
|
Mine Safety Disclosures
|
Item 5.
|
Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
|
9/14
|
|
9/15
|
|
9/16
|
|
9/17
|
|
9/18
|
|
9/19
|
|
|
|
|
|
|
|
|
|
||||||
Nuance Communications, Inc.
|
|
100.00
|
|
106.20
|
|
94.06
|
|
101.98
|
|
112.36
|
|
105.81
|
|
Russell 2000
|
|
100.00
|
|
101.25
|
|
116.91
|
|
141.15
|
|
162.66
|
|
148.20
|
|
S&P Software & Services Select
|
100.00
|
|
109.82
|
|
131.33
|
|
156.88
|
|
218.07
|
|
225.09
|
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Program (1)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(1)
|
||||||
July 1, 2019 - July 31, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
436,384,658
|
|
|
August 1, 2019 - August 31, 2019
|
|
391,114
|
|
|
$
|
15.34
|
|
|
391,114
|
|
|
$
|
430,383,689
|
|
September 1, 2019 - September 30, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
430,383,689
|
|
|
Total
|
|
391,114
|
|
|
|
|
391,114
|
|
|
|
|
Fiscal Year Ended September 30,
|
||||||||||||||||||
(In millions, except per share amounts)
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Continuing Operations (a):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenues
|
$
|
1,823.1
|
|
|
$
|
1,842.3
|
|
|
$
|
1,728.2
|
|
|
$
|
1,720.3
|
|
|
$
|
1,721.5
|
|
Gross profit
|
$
|
1,043.2
|
|
|
$
|
1,016.9
|
|
|
$
|
924.3
|
|
|
$
|
945.4
|
|
|
$
|
948.4
|
|
Income (loss) from operations
|
$
|
132.7
|
|
|
$
|
(117.5
|
)
|
|
$
|
16.5
|
|
|
$
|
88.1
|
|
|
$
|
54.9
|
|
(Benefit) provision for income taxes
|
$
|
(88.6
|
)
|
|
$
|
(62.3
|
)
|
|
$
|
23.7
|
|
|
$
|
10.2
|
|
|
$
|
29.4
|
|
Net income (loss) from continuing operations
|
$
|
114.3
|
|
|
$
|
(184.9
|
)
|
|
$
|
(178.3
|
)
|
|
$
|
(58.7
|
)
|
|
$
|
(140.3
|
)
|
Net Income (Loss) Per Share - continuing operations:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
$
|
0.40
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
|
$
|
(0.20
|
)
|
|
$
|
(0.44
|
)
|
Diluted
|
$
|
0.39
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
|
$
|
(0.20
|
)
|
|
$
|
(0.44
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
286.3
|
|
|
291.3
|
|
|
289.3
|
|
|
292.1
|
|
|
317.0
|
|
|||||
Diluted
|
290.1
|
|
|
291.3
|
|
|
289.3
|
|
|
292.1
|
|
|
317.0
|
|
|||||
Financial Position:
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents and marketable securities
|
$
|
764.8
|
|
|
$
|
473.5
|
|
|
$
|
874.1
|
|
|
$
|
608.1
|
|
|
$
|
568.8
|
|
Total assets
|
$
|
5,365.8
|
|
|
$
|
5,302.4
|
|
|
$
|
5,931.9
|
|
|
$
|
5,661.5
|
|
|
$
|
5,511.9
|
|
Total debt
|
$
|
1,936.4
|
|
|
$
|
2,185.4
|
|
|
$
|
2,617.4
|
|
|
$
|
2,433.2
|
|
|
$
|
2,103.1
|
|
Total deferred revenue (a)
|
$
|
701.7
|
|
|
$
|
765.0
|
|
|
$
|
670.5
|
|
|
$
|
615.0
|
|
|
$
|
555.4
|
|
Total stockholders’ equity
|
$
|
2,173.2
|
|
|
$
|
1,717.5
|
|
|
$
|
1,931.4
|
|
|
$
|
1,931.3
|
|
|
$
|
2,265.3
|
|
Selected Data and Ratios (a):
|
|
|
|
|
|
|
|
|
|
||||||||||
Working capital
|
$
|
553.0
|
|
|
$
|
199.1
|
|
|
$
|
254.6
|
|
|
$
|
378.9
|
|
|
$
|
378.5
|
|
Depreciation of property and equipment
|
$
|
55.2
|
|
|
$
|
60.4
|
|
|
$
|
53.3
|
|
|
$
|
59.6
|
|
|
$
|
59.4
|
|
Amortization of intangible assets
|
$
|
103.6
|
|
|
$
|
124.9
|
|
|
$
|
150.7
|
|
|
$
|
139.8
|
|
|
$
|
146.7
|
|
Gross margin percentage
|
57.2
|
%
|
|
55.2
|
%
|
|
53.5
|
%
|
|
55.0
|
%
|
|
55.1
|
%
|
•
|
Healthcare. Customers in our healthcare segment are broadly implementing EHR systems and are working to improve clinical documentation, improve quality of care, minimize physician burnout, integrate quality measures and aid reimbursement. These trends are driving a shift towards more integrated solutions that combine both Dragon Medical cloud-based solutions and transcription services. Recently, higher demand for more integrated solutions have offset declines in legacy, hosted transcription services. Additionally, we have been able to capitalize on healthcare providers’ shift towards hosted, or cloud-based solutions, and away from perpetual licenses, by adding new innovations to our Dragon Medical cloud solutions including new clinical language understanding and AI capabilities designed to increase productivity and improve clinical documentation at the point of care and within existing electronic medical work flow.
|
•
|
Enterprise. Consumer demand for 24/7, multi-channel access to customer service from the businesses they interact with is driving demand for our AI-powered omni-channel engagement solutions. We continue to enhance our technology capabilities with intelligent self-service and AI for customer service, and to extend the market for our on-demand omni-channel enterprise solutions into international markets, expand our sales and solutions for biometrics, and expand our core products and services portfolio.
|
•
|
Automotive. Demand for our embedded and cloud-based automotive solutions is being driven by the growth in personalized, automotive virtual assistants and connected services for cars and by auto manufacturers' desire to create a branded and personalized experience, capable of intelligently integrating users' smart phone and home device preferences and technologies.
|
•
|
Other. Our Other segment includes our SRS and Devices businesses. Our SRS business provides value-added services to mobile operators in India and Brazil (“Mobile Operator Services”) and voicemail transcription services to mobile operators in the rest of the world (“Voicemail-to-Text”). Our Devices business provides speech recognition solutions and predictive text technologies for handset devices. Our Mobile Operator Services has experienced dramatic market disruptions during fiscal year 2018. Our Devices revenue has been declining due to the ongoing consolidation of our handset manufacturer customer base and continued erosion of our penetration of the remaining market. During the fourth quarter of fiscal 2018, in connection with our comprehensive portfolio and business review efforts, we commenced a wind-down of our Devices and Mobile Operator Services businesses. In May 2019, we completed the sale of our Mobile Operator Services business in Brazil, and in July 2019, we completed the sale of our Mobile Operator Services business in India. The sale prices and any gains or losses were immaterial.
|
•
|
Discontinued Operations - Imaging. On November 11, 2018, we entered into a definitive stock purchase agreement, pursuant to which we agreed to sell our Imaging business and associated assets. On February 1, we completed the sale of the business and we received proceeds approximately $400.0 million, net of related fees and expenses, and subject to certain customary post-closing adjustments. As a result, for fiscal years 2019, 2018, and 2017, Imaging's results of operations have been included within discontinued operations for all the historical periods presented and its assets and liabilities within held for sale in our consolidated financial statements as of September 30, 2018.
|
•
|
Total revenues under ASC 606 was $1,823.1 million for the year ended September 30, 2019, as compared to $1,842.3 million under ASC 605 for the year ended September 30, 2018;
|
•
|
Net income from continuing operations under ASC 606 for the year ended September 30, 2019 was $114.3 million, compared to a net loss from continuing operations of $184.9 million under ASC 605 the year ended September 30, 2018;
|
•
|
Gross margins under ASC 606 for the year ended September 30, 2019 was 57.2%, compared to 55.2% under ASC 605 for the year ended September 30, 2018;
|
•
|
Operating margins under ASC 606 for the year ended September 30, 2019 was 7.3%, compared to (6.4)% under ASC 605 for year ended September 30, 2018; and
|
•
|
Operating cash flows from continuing operations increased by $4.7 million to $397.0 million for the year ended September 30, 2019, compared to $392.3 million for the year ended September 30, 2018.
|
•
|
Total deferred revenue decreased by 8% to $701.7 million, primarily as a result of the ASC 606 implementation, offset in part by the continued growth of our Automotive connected solutions and Healthcare bundled offerings.
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Professional services and hosting
|
$
|
1,044.7
|
|
|
$
|
1,082.0
|
|
|
$
|
1,045.7
|
|
|
$
|
966.6
|
|
|
3.5
|
%
|
|
8.2
|
%
|
Product and licensing
|
509.2
|
|
|
533.1
|
|
|
544.0
|
|
|
493.9
|
|
|
(2.0
|
)%
|
|
10.1
|
%
|
||||
Maintenance and support
|
269.2
|
|
|
243.7
|
|
|
252.6
|
|
|
267.7
|
|
|
(3.5
|
)%
|
|
(5.6
|
)%
|
||||
Total Revenues
|
$
|
1,823.1
|
|
|
$
|
1,858.8
|
|
|
$
|
1,842.3
|
|
|
$
|
1,728.2
|
|
|
0.9
|
%
|
|
6.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
United States
|
$
|
1,367.8
|
|
|
$
|
1,399.9
|
|
|
$
|
1,374.9
|
|
|
$
|
1,244.9
|
|
|
1.8
|
%
|
|
10.4
|
%
|
International
|
455.3
|
|
|
458.9
|
|
|
467.4
|
|
|
483.3
|
|
|
(1.8
|
)%
|
|
(3.3
|
)%
|
||||
Total Revenues
|
$
|
1,823.1
|
|
|
$
|
1,858.8
|
|
|
$
|
1,842.3
|
|
|
$
|
1,728.2
|
|
|
0.9
|
%
|
|
6.6
|
%
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Hosting revenue
|
$
|
826.4
|
|
|
$
|
850.6
|
|
|
$
|
771.1
|
|
|
$
|
733.8
|
|
|
10.3
|
%
|
|
5.1
|
%
|
Professional services revenue
|
218.3
|
|
|
231.3
|
|
|
274.6
|
|
|
232.7
|
|
|
(15.8
|
)%
|
|
18.0
|
%
|
||||
Hosting and professional services revenue
|
$
|
1,044.7
|
|
|
$
|
1,081.9
|
|
|
$
|
1,045.7
|
|
|
$
|
966.6
|
|
|
3.5
|
%
|
|
8.2
|
%
|
As a percentage of total revenues
|
57.3
|
%
|
|
58.2
|
%
|
|
56.8
|
%
|
|
55.9
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Product and licensing revenue
|
$
|
509.2
|
|
|
$
|
533.1
|
|
|
$
|
544.0
|
|
|
$
|
493.9
|
|
|
(2.0
|
)%
|
|
10.1
|
%
|
As a percentage of total revenues
|
27.9
|
%
|
|
28.7
|
%
|
|
29.5
|
%
|
|
28.6
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Maintenance and support revenue
|
$
|
269.2
|
|
|
$
|
243.7
|
|
|
$
|
252.6
|
|
|
$
|
267.7
|
|
|
(3.5
|
)%
|
|
(5.6
|
)%
|
As a percentage of total revenues
|
14.8
|
%
|
|
13.1
|
%
|
|
13.7
|
%
|
|
15.5
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Cost of hosting and professional services revenue
|
$
|
636.2
|
|
|
$
|
639.1
|
|
|
$
|
678.4
|
|
|
$
|
654.6
|
|
|
(5.8
|
)%
|
|
3.6
|
%
|
As a percentage of hosting and professional services revenue
|
60.9
|
%
|
|
59.1
|
%
|
|
64.9
|
%
|
|
67.7
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Cost of product and licensing revenue
|
$
|
73.3
|
|
|
$
|
67.4
|
|
|
$
|
56.8
|
|
|
$
|
54.1
|
|
|
18.7
|
%
|
|
5.0
|
%
|
As a percentage of product and licensing revenue
|
14.4
|
%
|
|
12.7
|
%
|
|
10.4
|
%
|
|
11.0
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Cost of maintenance and support revenue
|
$
|
33.6
|
|
|
$
|
33.8
|
|
|
$
|
39.3
|
|
|
$
|
37.2
|
|
|
(14.0
|
)%
|
|
5.6
|
%
|
As a percentage of maintenance and support revenue
|
12.5
|
%
|
|
13.9
|
%
|
|
15.6
|
%
|
|
13.9
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Research and development expenses
|
$
|
275.9
|
|
|
$
|
275.9
|
|
|
$
|
278.7
|
|
|
$
|
239.9
|
|
|
(1.0
|
)%
|
|
16.2
|
%
|
As a percentage of total revenues
|
15.1
|
%
|
|
14.8
|
%
|
|
15.1
|
%
|
|
13.9
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Sales and marketing expenses
|
$
|
303.5
|
|
|
$
|
309.4
|
|
|
$
|
311.7
|
|
|
$
|
324.4
|
|
|
(0.8
|
)%
|
|
(3.9
|
)%
|
As a percentage of total revenues
|
16.6
|
%
|
|
16.6
|
%
|
|
16.9
|
%
|
|
18.8
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
General and administrative expenses
|
$
|
175.0
|
|
|
$
|
175.0
|
|
|
$
|
225.9
|
|
|
$
|
163.1
|
|
|
(22.5
|
)%
|
|
38.5
|
%
|
As a percentage of total revenues
|
9.6
|
%
|
|
9.4
|
%
|
|
12.3
|
%
|
|
9.4
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||
Cost of revenues
|
$
|
36.8
|
|
|
$
|
50.9
|
|
|
$
|
57.9
|
|
|
(27.6
|
)%
|
|
(12.1
|
)%
|
Operating expenses
|
66.7
|
|
|
74.0
|
|
|
92.8
|
|
|
(9.8
|
)%
|
|
(20.3
|
)%
|
|||
Total amortization expenses
|
$
|
103.5
|
|
|
$
|
124.9
|
|
|
$
|
150.7
|
|
|
(17.1
|
)%
|
|
(17.1
|
)%
|
As a percentage of total revenues
|
5.7
|
%
|
|
6.8
|
%
|
|
8.7
|
%
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||
Transition and integration costs
|
$
|
8.1
|
|
|
$
|
16.1
|
|
|
$
|
15.2
|
|
|
(49.4
|
)%
|
|
5.9
|
%
|
Professional service fees
|
2.3
|
|
|
3.5
|
|
|
12.6
|
|
|
(32.7
|
)%
|
|
(72.2
|
)%
|
|||
Acquisition-related adjustments
|
(1.5
|
)
|
|
(3.4
|
)
|
|
(0.1
|
)
|
|
(54.8
|
)%
|
|
3,300.0
|
%
|
|||
Total acquisition-related costs, net
|
$
|
8.9
|
|
|
$
|
16.1
|
|
|
$
|
27.7
|
|
|
(44.7
|
)%
|
|
(41.9
|
)%
|
As a percentage of total revenue
|
0.5
|
%
|
|
0.9
|
%
|
|
1.6
|
%
|
|
|
|
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring Expenses
|
|
Other Charges
|
|
Total
|
||||||||||
Fiscal Year 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,679
|
|
|
$
|
191
|
|
|
4,870
|
|
|
$
|
—
|
|
|
4,870
|
|
||
Enterprise
|
5,037
|
|
|
933
|
|
|
5,970
|
|
|
—
|
|
|
5,970
|
|
|||||
Automotive
|
5,159
|
|
|
1,706
|
|
|
6,865
|
|
|
44,453
|
|
|
51,318
|
|
|||||
Other
|
1,457
|
|
|
337
|
|
|
1,794
|
|
|
3,306
|
|
|
5,100
|
|
|||||
Corporate
|
3,039
|
|
|
764
|
|
|
3,803
|
|
|
9,404
|
|
|
13,207
|
|
|||||
Total fiscal year 2019
|
$
|
19,371
|
|
|
$
|
3,931
|
|
|
$
|
23,302
|
|
|
$
|
57,163
|
|
|
$
|
80,465
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
11,563
|
|
|
$
|
25
|
|
|
$
|
11,588
|
|
|
$
|
—
|
|
|
$
|
11,588
|
|
Enterprise
|
4,217
|
|
|
2,243
|
|
|
6,460
|
|
|
—
|
|
|
6,460
|
|
|||||
Automotive
|
4,160
|
|
|
20
|
|
|
4,180
|
|
|
—
|
|
|
4,180
|
|
|||||
Other
|
1,473
|
|
|
647
|
|
|
2,120
|
|
|
7,103
|
|
|
9,223
|
|
|||||
Corporate
|
10,107
|
|
|
953
|
|
|
11,060
|
|
|
14,515
|
|
|
25,575
|
|
|||||
Total fiscal year 2018
|
$
|
31,520
|
|
|
$
|
3,888
|
|
|
$
|
35,408
|
|
|
$
|
21,618
|
|
|
$
|
57,026
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,283
|
|
|
$
|
870
|
|
|
$
|
5,153
|
|
|
$
|
8,758
|
|
|
$
|
13,911
|
|
Enterprise
|
2,141
|
|
|
3,480
|
|
|
5,621
|
|
|
—
|
|
|
5,621
|
|
|||||
Automotive
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|||||
Other
|
2,954
|
|
|
(15
|
)
|
|
2,939
|
|
|
10,773
|
|
|
13,712
|
|
|||||
Corporate
|
1,337
|
|
|
2,013
|
|
|
3,350
|
|
|
21,491
|
|
|
24,841
|
|
|||||
Total fiscal year 2017
|
$
|
12,553
|
|
|
$
|
6,348
|
|
|
$
|
18,901
|
|
|
$
|
41,022
|
|
|
$
|
59,923
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||
Interest income
|
$
|
13.7
|
|
|
$
|
9.3
|
|
|
$
|
6.9
|
|
|
46.9
|
%
|
|
34.7
|
%
|
Interest expense
|
(120.1
|
)
|
|
(137.3
|
)
|
|
(156.9
|
)
|
|
(12.5
|
)%
|
|
(12.5
|
)%
|
|||
Other expense, net
|
(0.5
|
)
|
|
(1.8
|
)
|
|
(21.2
|
)
|
|
(70.5
|
)%
|
|
(91.4
|
)%
|
|||
Total other expenses, net
|
$
|
(106.9
|
)
|
|
$
|
(129.7
|
)
|
|
$
|
(171.2
|
)
|
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||
(Benefit) provision for income taxes
|
$
|
(88.6
|
)
|
|
$
|
(62.3
|
)
|
|
$
|
23.7
|
|
|
42.2
|
%
|
|
(363.3
|
)%
|
Effective income tax rate
|
(344.1
|
)%
|
|
25.2
|
%
|
|
(15.3
|
)%
|
|
|
|
|
|
|
|
Fiscal Year 2019
|
|
Fiscal Year 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
% Change 2019 vs. 2018
|
|
% Change 2018 vs. 2017
|
||||||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||||||
Segment Revenues (a)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Healthcare
|
$
|
950.6
|
|
|
$
|
984.4
|
|
|
$
|
984.8
|
|
|
$
|
899.3
|
|
|
—
|
%
|
|
9.5
|
%
|
Enterprise
|
510.8
|
|
|
507.4
|
|
|
483.2
|
|
|
474.3
|
|
|
5.0
|
%
|
|
1.9
|
%
|
||||
Automotive
|
306.6
|
|
|
312.7
|
|
|
279.4
|
|
|
252.2
|
|
|
11.9
|
%
|
|
10.8
|
%
|
||||
Other
|
61.5
|
|
|
61.8
|
|
|
109.1
|
|
|
133.8
|
|
|
(43.3
|
)%
|
|
(18.5
|
)%
|
||||
Total segment revenues
|
1,829.5
|
|
|
1,866.3
|
|
|
1,856.5
|
|
|
1,759.6
|
|
|
0.5
|
%
|
|
5.5
|
%
|
||||
Less: acquisition related revenue adjustments
|
(6.3
|
)
|
|
(7.5
|
)
|
|
(14.2
|
)
|
|
(31.5
|
)
|
|
(46.8
|
)%
|
|
(54.9
|
)%
|
||||
Total revenues
|
$
|
1,823.2
|
|
|
$
|
1,858.8
|
|
|
$
|
1,842.3
|
|
|
$
|
1,728.1
|
|
|
0.9
|
%
|
|
6.6
|
%
|
Segment Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Healthcare
|
$
|
337.5
|
|
|
$
|
364.5
|
|
|
$
|
326.7
|
|
|
$
|
257.8
|
|
|
11.6
|
%
|
|
26.7
|
%
|
Enterprise
|
141.5
|
|
|
141.8
|
|
|
140.5
|
|
|
133.9
|
|
|
1.0
|
%
|
|
4.9
|
%
|
||||
Automotive
|
110.6
|
|
|
116.3
|
|
|
109.1
|
|
|
118.2
|
|
|
6.6
|
%
|
|
(7.7
|
)%
|
||||
Other
|
23.4
|
|
|
23.9
|
|
|
28.0
|
|
|
41.2
|
|
|
(14.7
|
)%
|
|
(32.0
|
)%
|
||||
Total segment profit
|
$
|
613.0
|
|
|
$
|
646.5
|
|
|
$
|
604.3
|
|
|
$
|
551.1
|
|
|
7.0
|
%
|
|
9.7
|
%
|
Segment Profit Margin
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Healthcare
|
35.5
|
%
|
|
37.0
|
%
|
|
33.2
|
%
|
|
28.7
|
%
|
|
3.9
|
|
|
4.5
|
|
||||
Enterprise
|
27.7
|
%
|
|
28.0
|
%
|
|
29.1
|
%
|
|
28.2
|
%
|
|
(1.1
|
)
|
|
0.9
|
|
||||
Automotive
|
36.1
|
%
|
|
37.2
|
%
|
|
39.1
|
%
|
|
46.9
|
%
|
|
(1.8
|
)
|
|
(7.8
|
)
|
||||
Other
|
38.1
|
%
|
|
38.7
|
%
|
|
25.7
|
%
|
|
30.8
|
%
|
|
13.0
|
|
|
(5.1
|
)
|
||||
Total segment profit margin
|
33.5
|
%
|
|
34.6
|
%
|
|
32.5
|
%
|
|
31.3
|
%
|
|
2.1
|
|
|
1.2
|
|
(a)
|
Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.
|
•
|
Healthcare segment revenue for the year ended September 30, 2019 reflected the up-front recognition of term license revenue from Clintegrity, Dragon Medical, and Diagnostic solutions under ASC 606. Under ASC 605, Healthcare segment revenue decreased by $0.4 million or 0.0%, primarily driven by:
|
•
|
Revenue from Dragon Medical cloud offerings increased by $74.6 million, or 54.0%, to $212.7 million for fiscal year 2019 from $138.1 million for fiscal year 2018, primarily due to the continued market penetration and customer transition to our cloud-based offering.
|
•
|
Revenue from transcription services decreased by $43.0 million, or 16.3%, to $220.5 million for fiscal year 2019 from $263.5 million for fiscal year 2018, primarily due to the continued erosion of our medical transcription services revenue and customer's transition to Dragon Medical cloud-based software.
|
•
|
Professional services revenue decreased by $59.1 million or 40.8%, to $85.8 million for fiscal year 2019 from $144.9 million for fiscal year 2018, primarily driven by lower revenue from EHR implementation and optimization services.
|
•
|
Enterprise segment revenue for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices, and the up-front recognition of term license revenue and related costs under ASC 606. Under ASC 605, Enterprise segment revenue increased by $24.2 million, or 5.0%, primarily due to the growth in our omni-channel hosting solutions.
|
•
|
Automotive segment revenue for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices under ASC 606. Under ASC 605, Automotive segment revenue increased by $33.3 million, or 11.9%, primarily due to higher royalties and hosting revenue driven by the continued growth in our speech recognition and infotainment platform services.
|
•
|
Other segment revenue for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices under ASC 606. Under ASC 605, Other segment revenue decreased by $47.3 million, or 43.3%, primarily due to the wind-down of Devices and the sale of Mobile Operator Services business in Brazil and India in fiscal year 2019.
|
•
|
Healthcare segment revenues increased by $85.5 million, or 9.5%, primarily driven by:
|
•
|
Revenue from Dragon Medical cloud offerings increased by $74.0 million, or 115.5%, to $138.1 million for fiscal year 2018 from $64.1 million for fiscal year 2017, primarily due to the continued market penetration and customer transition to our cloud-based offering, as well as the revenue loss in fiscal year 2017 due to the Malware Incident.
|
•
|
Revenue from transcription services decreased by $50.6 million, or 16.1%, to $263.5 million for fiscal year 2018 from $314.1 million for fiscal year 2017, primarily due to the continued erosion of our medical transcription services revenue and customer's transition to Dragon Medical cloud-based software.
|
•
|
Professional services revenue increased by $49.0 million or 51.0%, to $144.9 million for fiscal year 2018 from $96.0 million for fiscal year 2017, primarily driven by higher revenue from EHR implementation and optimization services.
|
•
|
Enterprise segment revenues increased by $8.9 million, or 1.9%, during fiscal year 2018 primarily due to higher contact center license and services revenue, offset in part by lower revenue from our inbound and outbound on-demand solutions.
|
•
|
Automotive segment revenues increased by $27.2 million, or 10.8%, during fiscal year 2018 primarily due to higher royalties and revenues from our hosting solutions driven by continued growth in our ASR and infotainment platform services.
|
•
|
Other segment revenue decreased by $24.7 million, or 18.5%, primarily due to the accelerated declines in both SRS and Devices businesses during fiscal year 2018. The decline in SRS was primarily due to the recent market disruptions in India and Brazil. These markets have experienced a dramatic recent disruption as a result of accelerated change in competition and business models for our SRS mobile operator customers, which has reduced demand for our services. The decline in our Devices business was primarily due to the ongoing consolidation of our handset manufacturer customer base, as well as continued erosion of our penetration of the remaining market.
|
•
|
Healthcare segment profit for the year ended September 30, 2019 reflected the upfront recognition of term license revenue and related costs for Clintegrity, Dragon Medical, and Diagnostic solutions under ASC 606. Under ASC 605, Healthcare segment profit increased by $37.8 million, or 11.6%, primarily due to higher gross margin. The gross margin improvement was primarily due to a favorable shift in mix to higher margin Dragon Medical cloud-based solution from lower margin medical transcription services, and lower revenue from EHR implementation and optimization services which carried lower margins. As a result, segment profit margin under ASC 605 increased by 3.9 percentage points to 37.0%.
|
•
|
Enterprise segment profit for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices and the up-front recognition of term license revenue and related costs under ASC 606. Under ASC 605, Enterprise segment profit increased by $1.4 million, or 1.0%, primarily due to higher segment revenue and lower sales and marketing expense, offset in part by lower gross margin. Gross margin decline was primarily due to lower licensing revenue, which carries higher margins. The decrease in sales and marketing expenses was primarily due to lower compensation expenses. As a result, segment profit margin under ASC 605 decreased by 1.1 percentage points to 28.0%.
|
•
|
Automotive segment profit for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices and the upfront recognition of term license costs under ASC 606. Under ASC 605, Automotive segment profit increased by $7.2 million, or 6.6%, primarily due to higher revenue, offset in part by lower gross margin, and higher operating expenses. Lower gross margin was primarily driven by the continued pricing
|
•
|
Other segment profit for the year ended September 30, 2019 reflected the allocation of contract consideration to multiple performance obligations based on standalone selling prices and the upfront recognition of term license costs under ASC 606. Under ASC 605, Other segment profit decreased by $4.1 million, or 14.7%, primarily driven by our costs saving initiatives related to the wind-down of our Devices and Mobile Operator Services businesses, offset in part by lower segment revenue.
|
•
|
Healthcare segment profit increased by $68.8 million, or 26.7%, primarily due to higher segment revenue and higher gross margin. Healthcare operating results for fiscal year 2017 was negatively impacted by the 2017 Malware Incident. The gross margin for fiscal year 2018 reflected a favorable shift in revenue mix towards higher margin Dragon Medical cloud-based offerings, offset in part by the increase in EHR implementation and optimization services which carried lower margins. As a result, segment profit margin increased by 4.5 percentage points, to 33.2% for fiscal year 2018.
|
•
|
Enterprise segment profit increased by $6.6 million, or 4.9%, primarily due to higher segment revenue, offset in part by lower gross margin. The lower gross margin was primarily due to higher infrastructure costs and increased headcount to support future growth. As a result, segment profit margin increased by 0.9 percentage points to 29.1% for fiscal year 2018 from 28.2% for fiscal year 2017.
|
•
|
Automotive segment profit decreased by $9.1 million, or 7.7%, primarily due to lower gross margin and higher R&D expenses, offset in part by higher revenue. The lower gross margin was primarily driven by increased professional services headcount to support implementation of our connected solutions across existing and new customer base. The higher R&D expense was primarily driven by our increased investment in new technologies. As a result, segment profit margin decreased by 7.8 percentage points to 39.1% for fiscal year 2018 from 46.9% for fiscal year 2017.
|
•
|
Other segment profit decreased by $13.2 million, or 32.0%, primarily due to lower revenue and the margin compression in SRS and Devices. Segment profit margin declined primarily due to lower revenues and relatively fixed costs and expenses structure. As more fully described in Note 4 to the accompanying consolidated financial statements, during the fourth quarter of fiscal 2018, in connection with our comprehensive portfolio and business review efforts, we commenced a wind-down of our Devices and Mobile Operator Services businesses.
|
•
|
A decrease of $74.7 million from changes in deferred revenue. Deferred revenue had a positive effect of $22.3 million on operating cash flows for the year ended September 30, 2019, as compared to $97.0 million for the year ended September 30, 2018, primarily due to the ASC 606 implementation using the modified retrospective approach in the current period;
|
•
|
A decrease of $47.8 million from operating cash flows from discontinued operations; offset in part by,
|
•
|
An increase of $56.6 million due to higher income before non-cash charges;
|
•
|
An increase of $22.8 million due to favorable changes in working capital, primarily due to the timing of cash payments.
|
•
|
An increase of $33.0 million driven by favorable changes in working capital excluding deferred revenue, primarily due to the timing of billing and collections; and
|
•
|
An increase of cash inflows of $45.9 million from deferred revenue. Deferred revenue contributed cash inflow of $97.0 million in fiscal year 2018, as compared to $51.0 million in fiscal year 2017, primarily driven by continued growth of our Automotive connected solutions and bundled offerings within our Healthcare segment.
|
•
|
Net proceeds of $407.0 million from the dispositions of businesses, net of transaction fees;
|
•
|
A decrease of $89.3 million in payments for business and asset acquisitions;
|
•
|
A decrease of $4.7 million in capital expenditures; offset in part by,
|
•
|
A decrease of $167.7 million in net proceeds from the sale and purchase of marketable securities and other investments.
|
•
|
An increase of $280.3 million in net proceeds from the sale and purchase of marketable securities and other investments; and
|
•
|
A decrease of $13.0 million in capital expenditures.
|
•
|
A decrease of $181.2 million in repayment and redemption of debt. During fiscal year 2019, we redeemed $300.0 million in aggregate principal of our 5.375% Senior Notes due 2020 with the net proceeds from the sale of Imaging. During fiscal year 2018, we redeemed approximately $331.2 million in aggregate principal of the 2.75% 2031 Debentures, and repurchased $150.0 million in aggregate principal amount of our 2020 Senior Notes.
|
•
|
A decrease of $24.8 million related to acquisition payments with extended payment terms;
|
•
|
A decrease of $6.0 million related to payments for taxes related to net share settlement of equity awards;
|
•
|
A decrease of $9.2 million for share repurchases; offset in part by,
|
•
|
An increase of $9.9 million due to the proceeds from sale of noncontrolling interests in a subsidiary.
|
•
|
A decrease in cash inflows of $837.5 million from debt issuance. During fiscal year 2017, the cash inflows from debt activities includes $495.0 million net proceeds from the issuance of 5.625% Senior Notes due 2026; and $343.6 million net proceeds from the issuance of our 1.25% 2025 Convertible Debentures;
|
•
|
An increase in cash outflows of $37.0 million related to share repurchases; and
|
•
|
An increase in cash outflows of $24.8 million related to acquisition payments with extended payment terms, offset in part by,
|
•
|
A decrease in cash outflows of $152.9 million from the redemption and repayment of debt. During fiscal year 2018, we redeemed approximately $331.2 million in aggregate principal of the 2.75% 2031 Debentures, and repurchased $150.0 million in aggregate principal of our 2020 Senior Notes. During fiscal year 2017, we repurchased $600.0 million in aggregate principal of our 2020 Senior Notes and $17.8 million in aggregate principal of our 2031 Convertible Debentures.
|
|
|
Payments Due by Fiscal Year Ended September 30,
|
||||||||||||||||||
Contractual Obligations
|
|
Total
|
|
2020
|
|
2021 and 2022
|
|
2023 and 2024
|
|
Thereafter
|
||||||||||
Convertible Debentures (1)
|
|
$
|
1,337.0
|
|
|
$
|
—
|
|
|
$
|
310.5
|
|
|
$
|
676.5
|
|
|
$
|
350.0
|
|
Senior Notes (2)
|
|
800.0
|
|
|
—
|
|
|
—
|
|
|
300.0
|
|
|
500.0
|
|
|||||
Interest payable on long-term debt (3)
|
|
344.0
|
|
|
62.5
|
|
|
120.2
|
|
|
98.2
|
|
|
63.1
|
|
|||||
Letter of Credit (4)
|
|
5.9
|
|
|
5.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Lease obligations and other liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating leases (5)
|
|
164.2
|
|
|
34.3
|
|
|
52.1
|
|
|
29.5
|
|
|
48.3
|
|
|||||
Operating leases under restructuring
|
|
16.7
|
|
|
5.0
|
|
|
4.6
|
|
|
3.9
|
|
|
3.2
|
|
|||||
Purchase commitments for inventory, property and equipment (6)
|
|
45.3
|
|
|
34.5
|
|
|
10.8
|
|
|
—
|
|
|
—
|
|
|||||
Total contractual cash obligations
|
|
$
|
2,713.1
|
|
|
$
|
142.2
|
|
|
$
|
498.2
|
|
|
$
|
1,108.1
|
|
|
$
|
964.6
|
|
(1)
|
The repayment schedule above assumes that payment is due on the first mandatory redemption date after September 30, 2019. As more fully described below, as of September 30, 2019, the holders had the right to convert all or any portion of their debentures until the close of business on October 1, 2019. As a result, the net carrying amounts of our convertible notes were included in current liabilities as of September 30, 2019. Upon the conclusion of the conversion period on October 1, 2019, none of the holders exercised their right to convert. As a result, the net carrying amounts of the convertible notes were reclassified back to long-term debt.
|
(2)
|
The repayment schedule reflects all the senior notes outstanding as of September 30, 2019. As more fully described below, on October 1, 2019, we redeemed all of the $300 million outstanding principal of the 2024 Senior Notes.
|
(3)
|
Interest per annum is due and payable semi-annually and is determined based on the outstanding principal as of September 30, 2019, the stated interest rate of each debt instrument and the assumed redemption dates discussed above.
|
(4)
|
Letters of Credit are in place primarily to secure future operating lease payments.
|
(5)
|
Obligations include contractual lease commitments related to facilities that have subsequently been subleased. As of September 30, 2019, we have subleased certain facilities with total sublease income of $15.2 million through fiscal year 2027.
|
(6)
|
These amounts include non-cancelable purchase commitments for property and equipment as well as inventory in the normal course of business to fulfill customer backlog.
|
•
|
identification of the contract, or contracts, with a customer;
|
•
|
identification of the performance obligations in the contract, including whether they are distinct within the context of the contract;
|
•
|
determination of the transaction price, including the constraint on variable consideration;
|
•
|
allocation of the transaction price to the performance obligations in the contract; and
|
•
|
recognition of revenue when, or as, performance obligations are satisfied.
|
•
|
the pricing of standalone sales (in the instances where available);
|
•
|
the pricing established by management when setting prices for deliverables that are intended to be sold on a standalone basis;
|
•
|
contractually stated prices for deliverables that are intended to be sold on a standalone basis; and
|
•
|
other pricing factors, such as the geographical region in which the products are sold and expected discounts based on the customer size and type.
|
|
September 30, 2019
|
||||||
|
Fair value
|
|
Conversion
value
|
|
Increase to
fair value
|
|
Increase to
conversion
value
|
2.75% 2031 Debentures
|
$45.2
|
|
$23.5
|
|
$0.6
|
|
$2.4
|
1.5% 2035 Debentures
|
$264.8
|
|
$185.1
|
|
$5.0
|
|
$18.5
|
1.0% 2035 Debentures
|
$641.8
|
|
$405.3
|
|
$12.5
|
|
$40.5
|
1.25 % 2025 Debentures
|
$346.9
|
|
$256.9
|
|
$18.7
|
|
$25.7
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Page
|
Consolidated Statements of Comprehensive Income (Loss)
|
|
•
|
Evaluating the design and testing operating effectiveness of controls relating to management’s adoption of ASC 606 including controls over: (i) evaluating the impact of the new accounting standard, (ii) evaluating the completeness and accuracy of relevant historical data for open contracts at the date of adoption, (iii) assessing the results and recording the impact of the adoption, and (iv) evaluating the design and testing the operating effectiveness of certain IT general controls relating to management’s implementation of the new revenue management system.
|
•
|
Evaluating management’s accounting policies and practices, including the reasonableness of management’s judgments and assumptions related to: (i) evaluation of performance obligations and whether they are distinct or non-distinct, (ii) consideration of income tax implications, and (iii) capitalization of contract costs including commissions.
|
•
|
Utilizing BDO technical specialists to assist in evaluating the technical merits of management’s accounting policies used as a basis of management’s ASC 606 adoption.
|
•
|
Testing of a sample of revenue contracts and underlying order documents recorded by management to evaluate proper processing within the new revenue management system.
|
•
|
Testing the completeness and accuracy of relevant inputs and outputs used in the adoption of ASC 606, identification of performance obligations and determination of standalone selling prices.
|
•
|
Evaluating the design and testing operating effectiveness of certain controls relating to management’s identification and assessment of distinct performance obligations in customer revenue contracts.
|
•
|
Evaluating management’s accounting policies and practices including the reasonableness of management’s judgments and assumptions relating to the evaluation of performance obligations and whether they are distinct or non-distinct.
|
•
|
Testing a sample of revenue contracts and underlying order documents to evaluate management’s identification of distinct performance obligations in revenue contracts.
|
•
|
Evaluating the design and testing the operating effectiveness of controls relating to management’s assessment of: (i) completeness and accuracy of the identified uncertain tax positions, (ii) evaluation of the technical merits of positions, and (iii) reasonableness of assumptions used in the determinations.
|
•
|
Evaluating management’s judgments and assessing the reasonableness of assumptions used in determining the units of account, recognition, measurement, and technical merits of UTPs.
|
•
|
Assessing management’s application of new and updated regulatory and legislative guidance in various jurisdictions and evaluating implications on the Company’s UTPs due to changes in legal structure of certain subsidiaries.
|
•
|
Utilizing BDO Tax and valuation specialists to assist in evaluating technical merits, reasonableness of management’s judgments and assumptions used in UTPs calculations and the overall reasonableness of conclusions reached.
|
|
/s/ BDO USA, LLP
|
|
BDO USA, LLP
|
|
/s/ BDO USA, LLP
|
|
BDO USA, LLP
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
|
(In thousands, except per share amounts)
|
||||||||||
Revenues:
|
|
|
|
|
|
|
|
|
|||
Hosting and professional services
|
$
|
1,044,670
|
|
|
$
|
1,045,722
|
|
|
$
|
966,566
|
|
Product and licensing
|
509,226
|
|
|
544,019
|
|
|
493,911
|
|
|||
Maintenance and support
|
269,196
|
|
|
252,557
|
|
|
267,698
|
|
|||
Total revenues
|
1,823,092
|
|
|
1,842,298
|
|
|
1,728,175
|
|
|||
Cost of revenues:
|
|
|
|
|
|
|
|
|
|||
Hosting and professional services
|
636,189
|
|
|
678,378
|
|
|
654,599
|
|
|||
Product and licensing
|
73,333
|
|
|
56,799
|
|
|
54,104
|
|
|||
Maintenance and support
|
33,564
|
|
|
39,324
|
|
|
37,243
|
|
|||
Amortization of intangible assets
|
36,833
|
|
|
50,886
|
|
|
57,892
|
|
|||
Total cost of revenues
|
779,919
|
|
|
825,387
|
|
|
803,838
|
|
|||
Gross profit
|
1,043,173
|
|
|
1,016,911
|
|
|
924,337
|
|
|||
Operating expenses:
|
|
|
|
|
|
|
|
|
|||
Research and development
|
275,886
|
|
|
278,735
|
|
|
239,925
|
|
|||
Sales and marketing
|
303,503
|
|
|
311,712
|
|
|
324,370
|
|
|||
General and administrative
|
175,008
|
|
|
225,884
|
|
|
163,065
|
|
|||
Amortization of intangible assets
|
66,730
|
|
|
73,997
|
|
|
92,839
|
|
|||
Acquisition-related costs, net
|
8,909
|
|
|
16,093
|
|
|
27,708
|
|
|||
Restructuring and other charges, net
|
80,465
|
|
|
57,026
|
|
|
59,923
|
|
|||
Impairment of goodwill and other intangible assets
|
—
|
|
|
170,941
|
|
|
—
|
|
|||
Total operating expenses
|
910,501
|
|
|
1,134,388
|
|
|
907,830
|
|
|||
Income (loss) from operations
|
132,672
|
|
|
(117,477
|
)
|
|
16,507
|
|
|||
Other income (expense):
|
|
|
|
|
|
|
|
|
|||
Interest income
|
13,705
|
|
|
9,327
|
|
|
6,922
|
|
|||
Interest expense
|
(120,095
|
)
|
|
(137,253
|
)
|
|
(156,889
|
)
|
|||
Other expense, net
|
(538
|
)
|
|
(1,821
|
)
|
|
(21,210
|
)
|
|||
Income (loss) before income taxes
|
25,744
|
|
|
(247,224
|
)
|
|
(154,670
|
)
|
|||
(Benefit) provision for income taxes
|
(88,594
|
)
|
|
(62,320
|
)
|
|
23,671
|
|
|||
Net income (loss) from continuing operations
|
114,338
|
|
|
(184,904
|
)
|
|
(178,341
|
)
|
|||
Net income from discontinued operations
|
99,472
|
|
|
24,976
|
|
|
27,345
|
|
|||
Net income (loss)
|
$
|
213,810
|
|
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
|
|
|
|
|
|
||||||
Net income (loss) per common share - basic:
|
|
|
|
|
|
|
|
|
|||
Continuing operations
|
$
|
0.40
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
Discontinued operations
|
0.35
|
|
|
0.08
|
|
|
0.10
|
|
|||
Total net income (loss) per basic common share
|
$
|
0.75
|
|
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
|
|
|
|
|
||||||
Net income (loss) per common share - diluted:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
0.39
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
Discontinued operations
|
0.35
|
|
|
0.08
|
|
|
0.10
|
|
|||
Total net income (loss) per diluted common share
|
$
|
0.74
|
|
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|||
Basic
|
286,347
|
|
|
291,318
|
|
|
289,348
|
|
|||
Diluted
|
290,125
|
|
|
291,318
|
|
|
289,348
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
|
(In thousands)
|
||||||||||
Net income (loss)
|
$
|
213,810
|
|
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
Other comprehensive (loss) income:
|
|
|
|
|
|
||||||
Foreign currency translation adjustment
|
(11,993
|
)
|
|
(23,973
|
)
|
|
13,027
|
|
|||
Reclassification of currency translation differences into earnings as a result of business disposition
|
5,605
|
|
|
—
|
|
|
—
|
|
|||
Pension adjustments
|
(3,768
|
)
|
|
2,644
|
|
|
1,774
|
|
|||
Unrealized gains (losses) on marketable securities
|
246
|
|
|
(192
|
)
|
|
(9
|
)
|
|||
Total other comprehensive (loss) income, net
|
(9,910
|
)
|
|
(21,521
|
)
|
|
14,792
|
|
|||
Comprehensive income (loss)
|
$
|
203,900
|
|
|
$
|
(181,449
|
)
|
|
$
|
(136,204
|
)
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
|
(ASC 606)
|
|
(ASC 605)
|
||||
|
(In thousands, except per share amounts)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
560,961
|
|
|
$
|
315,963
|
|
Marketable securities
|
186,555
|
|
|
135,579
|
|
||
Accounts receivable, less allowances for doubtful accounts of $10,662 and $9,823
|
308,601
|
|
|
347,873
|
|
||
Prepaid expenses and other current assets
|
199,096
|
|
|
94,814
|
|
||
Current assets held for sale
|
—
|
|
|
34,402
|
|
||
Total current assets
|
1,255,213
|
|
|
928,631
|
|
||
Marketable securities
|
17,287
|
|
|
21,932
|
|
||
Land, buildings and equipment, net
|
141,316
|
|
|
153,452
|
|
||
Goodwill
|
3,243,464
|
|
|
3,247,105
|
|
||
Intangible assets, net
|
356,932
|
|
|
450,001
|
|
||
Other assets
|
351,581
|
|
|
141,761
|
|
||
Long-term assets held for sale
|
—
|
|
|
359,497
|
|
||
Total assets
|
$
|
5,365,793
|
|
|
$
|
5,302,379
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
|
|
||
Current portion of long-term debt
|
1,142,870
|
|
|
—
|
|
||
Contingent and deferred acquisition payments
|
17,470
|
|
|
14,211
|
|
||
Accounts payable
|
104,865
|
|
|
80,912
|
|
||
Accrued expenses and other current liabilities
|
276,999
|
|
|
269,339
|
|
||
Deferred revenue
|
302,872
|
|
|
330,689
|
|
||
Current liabilities held for sale
|
—
|
|
|
69,013
|
|
||
Total current liabilities
|
1,845,076
|
|
|
764,164
|
|
||
Long-term debt
|
793,536
|
|
|
2,185,361
|
|
||
Deferred revenue, net of current portion
|
398,834
|
|
|
434,316
|
|
||
Deferred tax liabilities
|
54,216
|
|
|
49,931
|
|
||
Other liabilities
|
100,981
|
|
|
93,593
|
|
||
Long-term liabilities held for sale
|
—
|
|
|
57,518
|
|
||
Total liabilities
|
3,192,643
|
|
|
3,584,883
|
|
||
Commitments and contingencies (Note 18)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.001 par value per share; 560,000 shares authorized; 289,680 and 291,504 shares issued and 285,930 and 287,753 shares outstanding, respectively
|
290
|
|
|
291
|
|
||
Additional paid-in capital
|
2,597,889
|
|
|
2,597,693
|
|
||
Treasury stock, at cost (3,751 shares)
|
(16,788
|
)
|
|
(16,788
|
)
|
||
Accumulated other comprehensive loss
|
(132,773
|
)
|
|
(122,863
|
)
|
||
Accumulated deficit
|
(293,612
|
)
|
|
(740,837
|
)
|
||
Total Nuance Communications, Inc. stockholders' equity
|
2,155,006
|
|
|
1,717,496
|
|
||
Noncontrolling interests
|
18,144
|
|
|
—
|
|
||
Total stockholders’ equity
|
2,173,150
|
|
|
1,717,496
|
|
||
Total liabilities and stockholders’ equity
|
$
|
5,365,793
|
|
|
$
|
5,302,379
|
|
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Treasury Stock
|
|
Accumulated Other Comprehensive Loss
|
|
Accumulated Deficit
|
|
Noncontrolling Interests
|
|
Total Stockholders' Equity
|
||||||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
Balance at September 30, 2016
|
291,384
|
|
|
$
|
291
|
|
|
$
|
2,492,992
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(116,134
|
)
|
|
$
|
(429,031
|
)
|
|
$
|
—
|
|
|
$
|
1,931,330
|
|
Issuance of common stock under employee stock plans
|
10,709
|
|
|
11
|
|
|
17,372
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
17,383
|
|
|||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(3,377
|
)
|
|
(3
|
)
|
|
(55,129
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,132
|
)
|
|||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
160,575
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
160,575
|
|
|||||||
Repurchase and retirement of common stock
|
(5,797
|
)
|
|
(6
|
)
|
|
(99,071
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(99,077
|
)
|
|||||||
Net issuance of common stock in connection with acquisitions and collaboration agreements
|
1,019
|
|
|
1
|
|
|
16,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,347
|
|
|||||||
Equity portion of convertible debt issuance/retirement, net of tax effect
|
—
|
|
|
—
|
|
|
96,160
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
96,160
|
|
|||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(150,996
|
)
|
|
—
|
|
|
(150,996
|
)
|
|||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,792
|
|
|
—
|
|
|
—
|
|
|
14,792
|
|
|||||||
Balance at September 30, 2017
|
293,938
|
|
|
294
|
|
|
2,629,245
|
|
|
3,751
|
|
|
(16,788
|
)
|
|
(101,342
|
)
|
|
(580,027
|
)
|
|
—
|
|
|
1,931,382
|
|
|||||||
Prior period adjustment related to early adoption of ASU 2016-16
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(882
|
)
|
|
—
|
|
|
(882
|
)
|
|||||||
Issuance of common stock under employee stock plans
|
10,568
|
|
|
10
|
|
|
18,374
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,384
|
|
|||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(3,304
|
)
|
|
(3
|
)
|
|
(52,333
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,336
|
)
|
|||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
138,487
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
138,487
|
|
|||||||
Repurchase and retirement of common stock
|
(9,698
|
)
|
|
(10
|
)
|
|
(136,080
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(136,090
|
)
|
|||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(159,928
|
)
|
|
—
|
|
|
(159,928
|
)
|
|||||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,521
|
)
|
|
—
|
|
|
—
|
|
|
(21,521
|
)
|
|||||||
Balance at September 30, 2018
|
291,504
|
|
|
291
|
|
|
2,597,693
|
|
|
3,751
|
|
|
(16,788
|
)
|
|
(122,863
|
)
|
|
(740,837
|
)
|
|
—
|
|
|
1,717,496
|
|
|||||||
Accumulated adjustment related to the adoption of ASC 606
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
233,415
|
|
|
—
|
|
|
233,415
|
|
|||||||
Issuance of common stock under employee stock plans
|
8,981
|
|
|
9
|
|
|
16,588
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,597
|
|
|||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(2,645
|
)
|
|
(2
|
)
|
|
(42,552
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(42,554
|
)
|
|||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
161,371
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
161,371
|
|
|||||||
Repurchase and retirement of common stock
|
(8,160
|
)
|
|
(8
|
)
|
|
(126,930
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(126,938
|
)
|
|||||||
Noncontrolling interests
|
—
|
|
|
—
|
|
|
(8,281
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,144
|
|
|
9,863
|
|
|||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
213,810
|
|
|
—
|
|
|
213,810
|
|
|||||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,910
|
)
|
|
—
|
|
|
—
|
|
|
(9,910
|
)
|
|||||||
Balance at September 30, 2019
|
289,680
|
|
|
$
|
290
|
|
|
$
|
2,597,889
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(132,773
|
)
|
|
$
|
(293,612
|
)
|
|
$
|
18,144
|
|
|
$
|
2,173,150
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
|
(In thousands)
|
||||||||||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|||
Net income (loss) from continuing operations
|
$
|
114,338
|
|
|
$
|
(184,904
|
)
|
|
$
|
(178,341
|
)
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|||
Depreciation
|
55,227
|
|
|
60,355
|
|
|
53,268
|
|
|||
Amortization
|
103,563
|
|
|
124,883
|
|
|
150,731
|
|
|||
Stock-based compensation
|
141,212
|
|
|
142,909
|
|
|
142,901
|
|
|||
Non-cash interest expense
|
49,488
|
|
|
49,091
|
|
|
59,295
|
|
|||
Deferred tax (benefit) provision
|
(123,763
|
)
|
|
(86,841
|
)
|
|
5,226
|
|
|||
Loss (gain) on extinguishment of debt
|
910
|
|
|
(348
|
)
|
|
18,565
|
|
|||
Impairment of goodwill and other intangible assets
|
—
|
|
|
170,941
|
|
|
—
|
|
|||
Impairment of fixed assets
|
—
|
|
|
10,550
|
|
|
16,351
|
|
|||
Other
|
4,462
|
|
|
2,230
|
|
|
8,403
|
|
|||
Changes in operating assets and liabilities, excluding effects of acquisitions:
|
|
|
|
|
|
|
|
|
|||
Accounts receivable
|
1,058
|
|
|
16,996
|
|
|
(15,403
|
)
|
|||
Prepaid expenses and other assets
|
(25,076
|
)
|
|
(20,555
|
)
|
|
(14,858
|
)
|
|||
Accounts payable
|
22,922
|
|
|
(14,458
|
)
|
|
109
|
|
|||
Accrued expenses and other liabilities
|
30,344
|
|
|
24,451
|
|
|
3,557
|
|
|||
Deferred revenue
|
22,317
|
|
|
96,977
|
|
|
51,041
|
|
|||
Net cash provided by operating activities - continuing operations
|
397,002
|
|
|
392,277
|
|
|
300,845
|
|
|||
Net cash provided by operating activities - discontinued operations
|
4,355
|
|
|
52,149
|
|
|
78,022
|
|
|||
Net cash provided by operating activities
|
401,357
|
|
|
444,426
|
|
|
378,867
|
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|||
Proceeds from dispositions of businesses, net of transaction fees
|
407,043
|
|
|
—
|
|
|
—
|
|
|||
Capital expenditures
|
(44,185
|
)
|
|
(48,845
|
)
|
|
(61,835
|
)
|
|||
Payments for business and asset acquisitions, net of cash acquired
|
(20,873
|
)
|
|
(110,170
|
)
|
|
(113,769
|
)
|
|||
Purchases of marketable securities and other investments
|
(349,125
|
)
|
|
(201,995
|
)
|
|
(332,470
|
)
|
|||
Proceeds from sales and maturities of marketable securities and other investments
|
303,171
|
|
|
323,695
|
|
|
173,864
|
|
|||
Net cash provided by (used in) investing activities
|
296,031
|
|
|
(37,315
|
)
|
|
(334,210
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|||
Repayment and redemption of debt
|
(300,000
|
)
|
|
(481,172
|
)
|
|
(634,055
|
)
|
|||
Proceeds from issuance of long-term debt, net of issuance costs
|
—
|
|
|
—
|
|
|
837,482
|
|
|||
Payments for repurchase of common stock
|
(126,938
|
)
|
|
(136,090
|
)
|
|
(99,077
|
)
|
|||
Acquisition payments with extended payment terms
|
—
|
|
|
(24,842
|
)
|
|
—
|
|
|||
Proceeds from issuance of common stock from employee stock plans
|
16,597
|
|
|
18,384
|
|
|
17,383
|
|
|||
Payments for taxes related to net share settlement of equity awards
|
(49,428
|
)
|
|
(55,396
|
)
|
|
(54,099
|
)
|
|||
Proceeds from sale of noncontrolling interests in a subsidiary
|
9,863
|
|
|
—
|
|
|
—
|
|
|||
Other financing activities
|
(2,131
|
)
|
|
(1,232
|
)
|
|
(583
|
)
|
|||
Net cash (used in) provided by financing activities
|
(452,037
|
)
|
|
(680,348
|
)
|
|
67,051
|
|
|||
Effects of exchange rate changes on cash and cash equivalents
|
(353
|
)
|
|
(3,099
|
)
|
|
(1,029
|
)
|
|||
Net increase (decrease) in cash and cash equivalents
|
244,998
|
|
|
(276,336
|
)
|
|
110,679
|
|
|||
Cash and cash equivalents at beginning of year
|
315,963
|
|
|
592,299
|
|
|
481,620
|
|
|||
Cash and cash equivalents at end of year
|
$
|
560,961
|
|
|
$
|
315,963
|
|
|
$
|
592,299
|
|
1.
|
Organization and Presentation
|
•
|
estimated fair values of intangible assets;
|
•
|
estimated fair values of legal performance commitments to customers, assumed from the acquiree under existing contractual obligations (classified as deferred revenue);
|
•
|
estimated fair values of stock awards assumed from the acquiree that are included in the purchase price;
|
•
|
estimated fair value of required payments under contingent consideration provisions;
|
•
|
estimated income tax assets and liabilities assumed from the acquiree; and
|
•
|
estimated fair value of pre-acquisition contingencies assumed from the acquiree.
|
|
Allowance for Doubtful Accounts
|
|
Allowance
for Sales
Returns
|
||||
Balance at September 30, 2016
|
$
|
8,349
|
|
|
$
|
3,166
|
|
Bad debt provision
|
3,333
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
256
|
|
|
—
|
|
||
Revenue adjustments, net (a)
|
—
|
|
|
26,375
|
|
||
Balance at September 30, 2017
|
11,938
|
|
|
29,541
|
|
||
Bad debt provisions
|
2,377
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
(4,492
|
)
|
|
—
|
|
||
Revenue adjustments, net (b)
|
—
|
|
|
(23,396
|
)
|
||
Balance at September 30, 2018
|
9,823
|
|
|
6,145
|
|
||
Bad debt provisions
|
2,375
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
(1,536
|
)
|
|
—
|
|
||
Revenue adjustments, net
|
—
|
|
|
(765
|
)
|
||
Balance at September 30, 2019
|
$
|
10,662
|
|
|
$
|
5,380
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Transition and integration costs
|
$
|
8,131
|
|
|
$
|
16,059
|
|
|
$
|
15,192
|
|
Professional service fees
|
2,321
|
|
|
3,450
|
|
|
12,622
|
|
|||
Acquisition-related adjustments
|
(1,543
|
)
|
|
(3,416
|
)
|
|
(106
|
)
|
|||
Total
|
$
|
8,909
|
|
|
$
|
16,093
|
|
|
$
|
27,708
|
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
Foreign currency translation adjustment
|
$
|
(124,608
|
)
|
|
$
|
(118,220
|
)
|
Net unrealized losses on post-retirement benefits
|
(8,296
|
)
|
|
(4,528
|
)
|
||
Unrealized gains (losses) on marketable securities
|
131
|
|
|
(115
|
)
|
||
Accumulated other comprehensive loss
|
$
|
(132,773
|
)
|
|
$
|
(122,863
|
)
|
|
For the Year Ended September 30, 2019
|
|||||||
|
As reported, ASC 606
|
|
Effect of Implementation
|
|
As adjusted, ASC 605
|
|||
Revenues:
|
|
|
|
|
|
|||
Hosting and professional services
|
1,044,670
|
|
|
37,294
|
|
|
1,081,964
|
|
Product and licensing
|
509,226
|
|
|
23,870
|
|
|
533,096
|
|
Maintenance and support
|
269,196
|
|
|
(25,531
|
)
|
|
243,665
|
|
Total revenues
|
1,823,092
|
|
|
35,633
|
|
|
1,858,725
|
|
|
|
|
|
|
|
|||
Cost of revenues:
|
|
|
|
|
|
|||
Hosting and professional services
|
636,189
|
|
|
2,948
|
|
|
639,137
|
|
Product and licensing
|
73,333
|
|
|
(5,891
|
)
|
|
67,442
|
|
Maintenance and support
|
33,564
|
|
|
253
|
|
|
33,817
|
|
Amortization of intangible assets
|
36,833
|
|
|
—
|
|
|
36,833
|
|
Total cost of revenues
|
779,919
|
|
|
(2,690
|
)
|
|
777,229
|
|
|
|
|
|
|
|
|||
Sales and marketing
|
303,503
|
|
|
5,863
|
|
|
309,366
|
|
|
|
|
|
|
|
|||
(Benefit) provision for income taxes
|
(88,594
|
)
|
|
1,963
|
|
|
(86,631
|
)
|
|
For the Year Ended September 30, 2019
|
|||||||
|
As reported, ASC 606
|
|
Effect of Implementation
|
|
As adjusted, ASC 605
|
|||
Assets:
|
|
|
|
|
|
|||
Accounts receivable
|
308,601
|
|
|
31,072
|
|
|
339,673
|
|
Prepaid expenses and other current assets
|
199,096
|
|
|
(74,582
|
)
|
|
124,514
|
|
Other assets
|
351,581
|
|
|
(129,760
|
)
|
|
221,821
|
|
|
|
|
|
|
|
|||
Liabilities:
|
|
|
|
|
|
|||
Deferred revenue, current
|
302,872
|
|
|
20,704
|
|
|
323,576
|
|
Deferred revenue, net of current portion
|
398,834
|
|
|
16,122
|
|
|
414,956
|
|
Deferred tax liabilities
|
54,216
|
|
|
(16,635
|
)
|
|
37,581
|
|
Other long-term liabilities
|
100,981
|
|
|
(10,331
|
)
|
|
90,650
|
|
|
|
|
|
|
|
|||
Stockholders' Equity:
|
|
|
|
|
|
|||
Accumulated Deficit
|
(293,612
|
)
|
|
(181,496
|
)
|
|
(475,108
|
)
|
•
|
identification of the contract, or contracts, with a customer;
|
•
|
identification of the performance obligations in the contract, including whether they are distinct within the context of the contract;
|
•
|
determination of the transaction price, including the constraint on variable consideration;
|
•
|
allocation of the transaction price to the performance obligations in the contract; and
|
•
|
recognition of revenue when, or as, performance obligations are satisfied.
|
•
|
the pricing of standalone sales (in the instances where available);
|
•
|
the pricing established by management when setting prices for deliverables that are intended to be sold on a standalone basis;
|
•
|
contractually stated prices for deliverables that are intended to be sold on a standalone basis; and
|
•
|
other pricing factors, such as the geographical region in which the products are sold and expected discounts based on the customer size and type.
|
|
For the Year Ended September 30, 2019
|
||||||||||||||
|
Hosting and professional services
|
|
Product and licensing
|
|
Maintenance and support
|
|
Total
|
||||||||
Healthcare
|
$
|
546,037
|
|
|
$
|
246,788
|
|
|
$
|
156,905
|
|
|
$
|
949,730
|
|
Enterprise
|
316,247
|
|
|
82,073
|
|
|
111,758
|
|
|
510,078
|
|
||||
Automotive
|
131,027
|
|
|
170,532
|
|
|
262
|
|
|
301,821
|
|
||||
Other
|
51,359
|
|
|
9,833
|
|
|
271
|
|
|
61,463
|
|
||||
Total revenues
|
$
|
1,044,670
|
|
|
$
|
509,226
|
|
|
$
|
269,196
|
|
|
$
|
1,823,092
|
|
|
Contract assets
|
||
Balance October 1, 2018
|
$
|
168,595
|
|
Revenues recognized but not billed
|
326,818
|
|
|
Amounts reclassified to accounts receivable
|
(318,969
|
)
|
|
Balance September 30, 2019
|
$
|
176,444
|
|
|
Deferred revenue
|
||
Balance October 1, 2018
|
$
|
693,272
|
|
Amounts bill but not recognized
|
913,306
|
|
|
Revenue recognized
|
(904,872
|
)
|
|
Balance September 30, 2019
|
$
|
701,706
|
|
|
Within One Year
|
|
Two to Five Years
|
|
Greater than Five Years
|
|
Total
|
||||||||
Total revenue
|
$
|
767,407
|
|
|
$
|
1,155,910
|
|
|
$
|
176,498
|
|
|
$
|
2,099,815
|
|
|
From October 1, 2018 to February 1, 2019
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
Major line items constituting net income of Imaging:
|
|
|
|
|
|
||||||
Revenue (a)
|
$
|
67,430
|
|
|
$
|
209,363
|
|
|
$
|
211,187
|
|
Cost of revenue
|
16,946
|
|
|
48,183
|
|
|
49,962
|
|
|||
Research and development
|
7,557
|
|
|
26,588
|
|
|
26,172
|
|
|||
Sales and marketing (a)
|
28,433
|
|
|
76,593
|
|
|
73,760
|
|
|||
General and administrative
|
1,997
|
|
|
3,890
|
|
|
3,612
|
|
|||
Amortization of intangible assets
|
5,219
|
|
|
17,096
|
|
|
21,056
|
|
|||
Acquisition-related costs, net
|
(386
|
)
|
|
8
|
|
|
32
|
|
|||
Restructuring and other related charges
|
13,251
|
|
|
6,472
|
|
|
1,131
|
|
|||
Other
|
—
|
|
|
44
|
|
|
(193
|
)
|
|||
(Loss) income from discontinued operations before income taxes(a)
|
(5,587
|
)
|
|
30,489
|
|
|
35,655
|
|
|||
(Benefit) provision for income taxes
|
(2,688
|
)
|
|
5,513
|
|
|
8,310
|
|
|||
Gain on disposition
|
102,371
|
|
|
—
|
|
|
—
|
|
|||
Net income from discontinued operations
|
$
|
99,472
|
|
|
$
|
24,976
|
|
|
$
|
27,345
|
|
|
|
|
|
|
|
||||||
Supplemental Information:
|
|
|
|
|
|
||||||
Depreciation
|
$
|
391
|
|
|
$
|
1,995
|
|
|
$
|
2,397
|
|
Amortization
|
$
|
6,569
|
|
|
$
|
23,083
|
|
|
$
|
28,017
|
|
Stock compensation
|
$
|
7,103
|
|
|
$
|
7,876
|
|
|
$
|
11,371
|
|
|
September 30,
2018 |
||
|
(ASC 605)
|
||
Major classes of Imaging assets:
|
|
||
Accounts receivable, net
|
$
|
30,959
|
|
Prepaid expenses and other current assets
|
3,443
|
|
|
Land, building and equipment, net
|
2,442
|
|
|
Goodwill
|
257,352
|
|
|
Intangible assets, net
|
99,507
|
|
|
Other assets
|
196
|
|
|
Total assets classified as held for sale
|
$
|
393,899
|
|
|
|
||
Major classes of Imaging liabilities:
|
|
||
Accounts payable
|
$
|
3,604
|
|
Accrued expenses and other current liabilities
|
12,304
|
|
|
Deferred revenue
|
107,965
|
|
|
Other
|
2,658
|
|
|
Total liabilities classified as held for sale
|
$
|
126,531
|
|
|
Healthcare
|
|
Enterprise
|
|
Former Mobile
|
|
Automotive
|
|
Other
|
|
Total
|
||||||||||||
Balance as of September 30, 2017
|
$
|
1,418,334
|
|
|
$
|
673,472
|
|
|
$
|
1,241,010
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,332,816
|
|
Acquisitions
|
14,936
|
|
|
—
|
|
|
—
|
|
|
50,193
|
|
|
—
|
|
|
65,129
|
|
||||||
Purchase accounting adjustments
|
(705
|
)
|
|
—
|
|
|
2,697
|
|
|
(3,275
|
)
|
|
—
|
|
|
(1,283
|
)
|
||||||
Reorganization (Note 23)
|
—
|
|
|
11,991
|
|
|
(1,249,051
|
)
|
|
1,080,453
|
|
|
156,607
|
|
|
—
|
|
||||||
Impairment charge (a)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(141,781
|
)
|
|
(141,781
|
)
|
||||||
Effect of foreign currency translation
|
(2,240
|
)
|
|
(2,116
|
)
|
|
5,344
|
|
|
(7,424
|
)
|
|
(1,340
|
)
|
|
(7,776
|
)
|
||||||
Balance as of September 30, 2018
|
1,430,325
|
|
|
683,347
|
|
|
—
|
|
|
1,119,947
|
|
|
13,486
|
|
|
3,247,105
|
|
||||||
Acquisitions
|
8,785
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,785
|
|
||||||
Purchase accounting adjustments
|
113
|
|
|
—
|
|
|
—
|
|
|
(171
|
)
|
|
—
|
|
|
(58
|
)
|
||||||
Effect of foreign currency translation
|
(4,079
|
)
|
|
(3,444
|
)
|
|
—
|
|
|
(4,208
|
)
|
|
(637
|
)
|
|
(12,368
|
)
|
||||||
Balance as of September 30, 2019
|
$
|
1,435,144
|
|
|
$
|
679,903
|
|
|
$
|
—
|
|
|
$
|
1,115,568
|
|
|
$
|
12,849
|
|
|
$
|
3,243,464
|
|
|
September 30, 2019
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Weighted Average Remaining Life (Years)
|
||||||
Customer relationships
|
$
|
605,736
|
|
|
$
|
(350,695
|
)
|
|
$
|
255,041
|
|
|
5.0
|
Technology and patents
|
264,151
|
|
|
(166,670
|
)
|
|
97,481
|
|
|
3.5
|
|||
Trade names, trademarks, and other
|
28,961
|
|
|
(24,551
|
)
|
|
4,410
|
|
|
1.2
|
|||
Total
|
$
|
898,848
|
|
|
$
|
(541,916
|
)
|
|
$
|
356,932
|
|
|
|
|
September 30, 2018
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Weighted Average Remaining Life (Years)
|
||||||
Customer relationships
|
$
|
605,784
|
|
|
$
|
(289,218
|
)
|
|
$
|
316,566
|
|
|
5.9
|
Technology and patents
|
292,766
|
|
|
(169,806
|
)
|
|
122,960
|
|
|
3.8
|
|||
Trade names, trademarks, and other
|
28,985
|
|
|
(18,510
|
)
|
|
10,475
|
|
|
1.9
|
|||
Total
|
$
|
927,535
|
|
|
$
|
(477,534
|
)
|
|
$
|
450,001
|
|
|
|
Year Ending September 30,
|
|
Cost of Revenue
|
|
Other Operating Expenses
|
|
Total
|
||||||
2020
|
|
$
|
33,628
|
|
|
$
|
60,680
|
|
|
$
|
94,308
|
|
2021
|
|
25,286
|
|
|
55,891
|
|
|
81,177
|
|
|||
2022
|
|
20,019
|
|
|
51,830
|
|
|
71,849
|
|
|||
2023
|
|
13,507
|
|
|
39,585
|
|
|
53,092
|
|
|||
2024
|
|
5,041
|
|
|
22,809
|
|
|
27,850
|
|
|||
Thereafter
|
|
—
|
|
|
28,656
|
|
|
28,656
|
|
|||
Total
|
|
$
|
97,481
|
|
|
$
|
259,451
|
|
|
$
|
356,932
|
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
|
(ASC 606)
|
|
(ASC 605)
|
||||
Trade accounts receivable
|
$
|
324,643
|
|
|
$
|
330,515
|
|
Unbilled accounts receivable under long-term contracts
|
—
|
|
|
33,326
|
|
||
Gross accounts receivable
|
324,643
|
|
|
363,841
|
|
||
Less: allowance for doubtful accounts
|
(10,662
|
)
|
|
(9,823
|
)
|
||
Less: allowance for sales returns
|
(5,380
|
)
|
|
(6,145
|
)
|
||
Accounts receivable, net
|
$
|
308,601
|
|
|
$
|
347,873
|
|
|
Useful Life (In Years)
|
|
September 30, 2019
|
|
September 30, 2018
|
|||||
Land
|
—
|
|
|
$
|
2,400
|
|
|
$
|
2,400
|
|
Building
|
30
|
|
|
6,696
|
|
|
5,409
|
|
||
Machinery and equipment
|
3-5
|
|
|
167,789
|
|
|
163,359
|
|
||
Computers, software and equipment
|
3-5
|
|
|
163,906
|
|
|
179,461
|
|
||
Leasehold improvements
|
2-15
|
|
|
36,759
|
|
|
34,970
|
|
||
Furniture and fixtures
|
5-7
|
|
|
17,222
|
|
|
17,249
|
|
||
Construction in progress
|
—
|
|
|
21,751
|
|
|
2,088
|
|
||
Subtotal
|
|
|
|
416,523
|
|
|
404,936
|
|
||
Less: accumulated depreciation
|
|
|
|
(275,207
|
)
|
|
(251,484
|
)
|
||
Land, building and equipment, net
|
|
|
|
$
|
141,316
|
|
|
$
|
153,452
|
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
Compensation
|
$
|
132,887
|
|
|
$
|
174,984
|
|
Accrued interest payable
|
19,302
|
|
|
21,326
|
|
||
Cost of revenue related liabilities
|
58,049
|
|
|
30,432
|
|
||
Consulting and professional fees
|
24,297
|
|
|
21,220
|
|
||
Facilities related liabilities
|
4,595
|
|
|
4,621
|
|
||
Sales and marketing incentives
|
2,692
|
|
|
1,889
|
|
||
Sales and other taxes payable
|
6,948
|
|
|
5,983
|
|
||
Other
|
28,229
|
|
|
8,884
|
|
||
Total
|
$
|
276,999
|
|
|
$
|
269,339
|
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
5.625% Senior Notes due 2026, net of deferred issuance costs of $4.5 million and $5.1 million, respectively. Effective interest rate 5.625%.
|
$
|
495,518
|
|
|
$
|
494,915
|
|
5.375% Senior Notes due 2020, net of deferred issuance costs of $1.2 million. Effective interest rate 5.375%.
|
—
|
|
|
298,759
|
|
||
6.000% Senior Notes due 2024, net of deferred issuance costs of $1.5 million and $1.8 million, respectively. Effective interest rate 6.000%.
|
298,529
|
|
|
298,220
|
|
||
1.00% Convertible Debentures due 2035, net of unamortized discount of $91.6 million and $116.9 million, respectively, and deferred issuance costs of $4.3 million and $5.6 million, respectively. Effective interest rate 5.622%.
|
580,639
|
|
|
553,973
|
|
||
2.75% Convertible Debentures due 2031. Effective interest rate 7.432%.
|
46,568
|
|
|
46,568
|
|
||
1.25% Convertible Debentures due 2025, net of unamortized discount of $71.6 million and $82.4 million, respectively, and deferred issuance costs of $3.1 million and $3.7 million, respectively. Effective interest rate 5.578%.
|
275,257
|
|
|
263,863
|
|
||
1.50% Convertible Debentures due 2035, net of unamortized discount of $22.7 million and $32.8 million, respectively, and deferred issuance costs of $0.8 million and $1.1 million, respectively. Effective interest rate 5.394%.
|
240,406
|
|
|
229,906
|
|
||
Deferred issuance costs related to our Revolving Credit Facility
|
(511
|
)
|
|
(843
|
)
|
||
Total debt
|
1,936,406
|
|
|
2,185,361
|
|
||
Less: current portion
|
(1,142,870
|
)
|
|
—
|
|
||
Total long-term debt
|
$
|
793,536
|
|
|
$
|
2,185,361
|
|
Fiscal Year
|
|
Convertible Debentures (1)
|
|
Senior Notes (2)
|
|
Total
|
||||||
2020
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
2022
|
|
310,464
|
|
|
—
|
|
|
310,464
|
|
|||
2023
|
|
676,488
|
|
|
—
|
|
|
676,488
|
|
|||
2024
|
|
—
|
|
|
300,000
|
|
|
300,000
|
|
|||
Thereafter
|
|
350,000
|
|
|
500,000
|
|
|
850,000
|
|
|||
Total before unamortized discount
|
|
1,336,952
|
|
|
800,000
|
|
|
2,136,952
|
|
|||
Less: unamortized discount and issuance costs
|
|
(194,082
|
)
|
|
(6,464
|
)
|
|
(200,546
|
)
|
|||
Total long-term debt
|
|
$
|
1,142,870
|
|
|
$
|
793,536
|
|
|
$
|
1,936,406
|
|
(1)
|
The repayment schedule above assumes that payment is due on the first contractual redemption date after September 30, 2019. As more fully described below, as of September 30, 2019, the holders had the right to convert all or any portion of their debentures until the close of business on October 1, 2019. As a result, the net carrying amounts of our convertible notes were included in current liabilities as of September 30, 2019. Upon the conclusion of the conversion period on October 1, 2019, none of the holders exercised their right to convert. As a result, the net carrying amounts of the convertible notes were reclassified back to long-term debt.
|
(2)
|
The repayment schedule reflects all the senior notes outstanding as of September 30, 2019. As more fully described below, on October 1, 2019, we redeemed all of the $300 million outstanding principal of the 2024 Senior Notes.
|
|
|
|
|
|
|
|
||||
Derivatives Not Designated as Hedges:
|
|
Balance Sheet Classification
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
Foreign currency contracts
|
|
Prepaid expenses and other current assets
|
|
$
|
597
|
|
|
$
|
143
|
|
Foreign currency contracts
|
|
Accrued expenses and other liabilities
|
|
$
|
(327
|
)
|
|
$
|
(1,192
|
)
|
|
|
Income Statement Classification Income (loss) recognized
|
|
September 30,
|
||||||||||
Derivatives Not Designated as Hedges:
|
|
|
2019
|
|
2018
|
|
2017
|
|||||||
Foreign currency contracts
|
|
Other income (expense)
|
|
$
|
1,816
|
|
|
$
|
(3,616
|
)
|
|
$
|
6,811
|
|
•
|
Level 1: Quoted prices for identical assets or liabilities in active markets.
|
•
|
Level 2: Observable inputs other than those described as Level 1.
|
•
|
Level 3: Unobservable inputs that are supportable by little or no market activities and are based on significant assumptions and estimates.
|
|
September 30, 2019
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds (a)
|
$
|
217,861
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
217,861
|
|
Time deposits(b)
|
|
|
|
115,913
|
|
|
—
|
|
|
115,913
|
|
||||
Commercial paper, $77,089 at cost(b)
|
—
|
|
|
77,494
|
|
|
—
|
|
|
77,494
|
|
||||
Corporate notes and bonds, $37,504 at cost(b)
|
|
|
|
37,566
|
|
|
—
|
|
|
37,566
|
|
||||
Foreign currency exchange contracts(b)
|
|
|
|
597
|
|
|
—
|
|
|
597
|
|
||||
Total assets at fair value
|
$
|
217,861
|
|
|
$
|
231,570
|
|
|
$
|
—
|
|
|
$
|
449,431
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency exchange contracts(b)
|
|
|
|
$
|
(327
|
)
|
|
|
|
|
$
|
(327
|
)
|
||
Contingent acquisition payments(c)
|
|
|
|
|
|
|
(2,925
|
)
|
|
(2,925
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(327
|
)
|
|
$
|
(2,925
|
)
|
|
$
|
(3,252
|
)
|
|
September 30, 2018
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds(a)
|
$
|
200,004
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
200,004
|
|
Time deposits(b)
|
—
|
|
|
88,158
|
|
|
—
|
|
|
88,158
|
|
||||
Commercial paper, $27,194 at cost(b)
|
—
|
|
|
27,363
|
|
|
—
|
|
|
27,363
|
|
||||
Corporate notes and bonds, $57,563 at cost(b)
|
—
|
|
|
57,417
|
|
|
—
|
|
|
57,417
|
|
||||
Foreign currency exchange contracts(b)
|
—
|
|
|
143
|
|
|
—
|
|
|
143
|
|
||||
Total assets at fair value
|
$
|
200,004
|
|
|
$
|
173,081
|
|
|
$
|
—
|
|
|
$
|
373,085
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency exchange contracts(b)
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
Contingent acquisition payments(c)
|
—
|
|
|
—
|
|
|
(4,000
|
)
|
|
(4,000
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
|
$
|
(4,000
|
)
|
|
$
|
(5,192
|
)
|
(a)
|
Money market funds and time deposits with original maturity of 90 days or less are included within cash and cash equivalents in the consolidated balance sheets and are valued at quoted market prices in active markets.
|
|
Amount
|
||
Balance as of September 30, 2017
|
$
|
8,648
|
|
Earn-out liability established at time of acquisition
|
2,000
|
|
|
Payments and foreign currency translation
|
(8,188
|
)
|
|
Adjustments to fair value included in acquisition-related costs, net
|
1,540
|
|
|
Balance as of September 30, 2018
|
4,000
|
|
|
Earn-out liability established at time of acquisition
|
1,500
|
|
|
Payments and foreign currency translation
|
(2,550
|
)
|
|
Adjustments to fair value included in acquisition-related costs, net
|
(25
|
)
|
|
Balance as of September 30, 2019
|
$
|
2,925
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Personnel
|
$
|
19,371
|
|
|
$
|
31,520
|
|
|
$
|
12,553
|
|
Facilities
|
3,931
|
|
|
3,888
|
|
|
6,348
|
|
|||
Total restructuring charges
|
23,302
|
|
|
35,408
|
|
|
18,901
|
|
|||
Other charges
|
57,163
|
|
|
21,618
|
|
|
41,022
|
|
|||
Total restructuring and other charges, net
|
$
|
80,465
|
|
|
$
|
57,026
|
|
|
$
|
59,923
|
|
|
Personnel
|
|
Facilities
|
|
Total
|
||||||
Balance at September 30, 2016
|
$
|
2,599
|
|
|
$
|
9,875
|
|
|
$
|
12,474
|
|
Restructuring charges, net
|
12,553
|
|
|
6,348
|
|
|
18,901
|
|
|||
Non-cash adjustment
|
—
|
|
|
(1,374
|
)
|
|
(1,374
|
)
|
|||
Cash payments
|
(13,678
|
)
|
|
(6,580
|
)
|
|
(20,258
|
)
|
|||
Balance at September 30, 2017
|
1,474
|
|
|
8,269
|
|
|
9,743
|
|
|||
Restructuring charges, net
|
31,520
|
|
|
3,888
|
|
|
35,408
|
|
|||
Non-cash adjustment
|
—
|
|
|
(998
|
)
|
|
(998
|
)
|
|||
Cash payments
|
(22,438
|
)
|
|
(4,658
|
)
|
|
(27,096
|
)
|
|||
Balance at September 30, 2018
|
10,556
|
|
|
6,501
|
|
|
17,057
|
|
|||
Restructuring charges, net
|
19,371
|
|
|
3,931
|
|
|
23,302
|
|
|||
Non-cash adjustment
|
—
|
|
|
(102
|
)
|
|
(102
|
)
|
|||
Cash payments
|
(25,971
|
)
|
|
(6,681
|
)
|
|
(32,652
|
)
|
|||
Balance at September 30, 2019
|
$
|
3,956
|
|
|
$
|
3,649
|
|
|
$
|
7,605
|
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
||||||||||
Fiscal Year 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,679
|
|
|
$
|
191
|
|
|
$
|
4,870
|
|
|
$
|
—
|
|
|
$
|
4,870
|
|
Enterprise
|
5,037
|
|
|
933
|
|
|
5,970
|
|
|
—
|
|
|
5,970
|
|
|||||
Automotive
|
5,159
|
|
|
1,706
|
|
|
6,865
|
|
|
44,453
|
|
|
51,318
|
|
|||||
Other
|
1,457
|
|
|
337
|
|
|
1,794
|
|
|
3,306
|
|
|
5,100
|
|
|||||
Corporate
|
3,039
|
|
|
764
|
|
|
3,803
|
|
|
9,404
|
|
|
13,207
|
|
|||||
Total fiscal year 2019
|
$
|
19,371
|
|
|
$
|
3,931
|
|
|
$
|
23,302
|
|
|
$
|
57,163
|
|
|
$
|
80,465
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
11,563
|
|
|
$
|
25
|
|
|
$
|
11,588
|
|
|
$
|
—
|
|
|
$
|
11,588
|
|
Enterprise
|
4,217
|
|
|
2,243
|
|
|
6,460
|
|
|
—
|
|
|
6,460
|
|
|||||
Automotive
|
4,160
|
|
|
20
|
|
|
4,180
|
|
|
—
|
|
|
4,180
|
|
|||||
Other
|
1,473
|
|
|
647
|
|
|
2,120
|
|
|
7,103
|
|
|
9,223
|
|
|||||
Corporate
|
10,107
|
|
|
953
|
|
|
11,060
|
|
|
14,515
|
|
|
25,575
|
|
|||||
Total fiscal year 2018
|
$
|
31,520
|
|
|
$
|
3,888
|
|
|
$
|
35,408
|
|
|
$
|
21,618
|
|
|
$
|
57,026
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,283
|
|
|
$
|
870
|
|
|
$
|
5,153
|
|
|
$
|
8,758
|
|
|
$
|
13,911
|
|
Enterprise
|
2,141
|
|
|
3,480
|
|
|
5,621
|
|
|
—
|
|
|
5,621
|
|
|||||
Automotive
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|||||
Other
|
2,954
|
|
|
(15
|
)
|
|
2,939
|
|
|
10,773
|
|
|
13,712
|
|
|||||
Corporate
|
1,337
|
|
|
2,013
|
|
|
3,350
|
|
|
21,491
|
|
|
24,841
|
|
|||||
Total fiscal year 2017
|
$
|
12,553
|
|
|
$
|
6,348
|
|
|
$
|
18,901
|
|
|
$
|
41,022
|
|
|
$
|
59,923
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
|
(Dollars in thousands)
|
||||||||||
Interest paid
|
$
|
72,630
|
|
|
$
|
93,121
|
|
|
$
|
91,718
|
|
Income taxes paid
|
$
|
24,056
|
|
|
$
|
18,485
|
|
|
$
|
21,700
|
|
|
Year Ended September 30,
|
||||||||||
2019
|
|
2018
|
|
2017
|
|||||||
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
Numerator:
|
|
|
|
|
|
||||||
Net income (loss) from continuing operations
|
$
|
114,338
|
|
|
$
|
(184,904
|
)
|
|
$
|
(178,341
|
)
|
Net income from discontinued operations
|
99,472
|
|
|
24,976
|
|
|
27,345
|
|
|||
Net income (loss)
|
$
|
213,810
|
|
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
|
|
|
|
|
|
||||||
Denominator:
|
|
|
|
|
|
||||||
Weighted average common shares outstanding — Basic
|
286,347
|
|
|
291,318
|
|
|
289,348
|
|
|||
Dilutive effect of employee stock compensation plans (a)
|
3,778
|
|
|
—
|
|
|
—
|
|
|||
Weighted average common shares outstanding — Diluted
|
290,125
|
|
|
291,318
|
|
|
289,348
|
|
|||
|
|
|
|
|
|
||||||
Net income (loss) per common share - basic:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
0.40
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
Discontinued operations
|
0.35
|
|
|
0.08
|
|
|
0.10
|
|
|||
Total net income (loss) per basic common share
|
$
|
0.75
|
|
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
|
|
|
|
|
||||||
Net income (loss) per common share - diluted:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
0.39
|
|
|
$
|
(0.63
|
)
|
|
$
|
(0.62
|
)
|
Discontinued operations
|
0.35
|
|
|
0.08
|
|
|
0.10
|
|
|||
Total net income (loss) per diluted common share
|
$
|
0.74
|
|
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
|
|
|
|
|
||||||
Anti-dilutive equity instruments excluded from the calculation
|
1,047
|
|
|
528
|
|
|
328
|
|
|||
Contingently issuable awards excluded from the calculation (a)
|
1,786
|
|
|
4,434
|
|
|
1,721
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Cost of professional services and hosting
|
$
|
28,523
|
|
|
$
|
31,094
|
|
|
$
|
28,532
|
|
Cost of product and licensing
|
855
|
|
|
814
|
|
|
348
|
|
|||
Cost of maintenance and support
|
1,314
|
|
|
3,322
|
|
|
2,161
|
|
|||
Research and development
|
38,454
|
|
|
38,077
|
|
|
30,540
|
|
|||
Sales and marketing
|
34,360
|
|
|
35,838
|
|
|
39,037
|
|
|||
General and administrative
|
37,706
|
|
|
33,764
|
|
|
42,283
|
|
|||
Total
|
$
|
141,212
|
|
|
$
|
142,909
|
|
|
$
|
142,901
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value(a)
|
|||||
Outstanding at September 30, 2016
|
1,965,826
|
|
|
$
|
15.01
|
|
|
|
|
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Exercised/Repurchased(b)
|
(1,932,286
|
)
|
|
$
|
14.98
|
|
|
|
|
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Expired
|
(9,733
|
)
|
|
$
|
20.01
|
|
|
|
|
|
|
|
Outstanding at September 30, 2017
|
23,807
|
|
|
$
|
15.39
|
|
|
|
|
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|||
Exercised
|
(2,963
|
)
|
|
$
|
2.61
|
|
|
|
|
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
|
|
|
|
||
Expired
|
(1,700
|
)
|
|
$
|
15.99
|
|
|
|
|
|
|
|
Outstanding at September 30, 2018
|
19,144
|
|
|
$
|
17.31
|
|
|
|
|
|
||
Granted
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Exercised
|
(3,314
|
)
|
|
$
|
7.22
|
|
|
|
|
|
||
Forfeited
|
—
|
|
|
—
|
|
|
|
|
|
|||
Expired
|
(4,528
|
)
|
|
$
|
17.89
|
|
|
|
|
|
||
Outstanding at September 30, 2019
|
11,302
|
|
|
$
|
20.04
|
|
|
2.6 years
|
|
$
|
0.1
|
million
|
Exercisable at September 30, 2019
|
11,302
|
|
|
$
|
20.04
|
|
|
2.6 years
|
|
$
|
0.1
|
million
|
Exercisable at September 30, 2018
|
19,144
|
|
|
|
|
|
|
|
|
|
||
Exercisable at September 30, 2017
|
23,798
|
|
|
|
|
|
|
|
|
|
(a)
|
The aggregate intrinsic value represents any excess of the closing price of our common stock of $16.31 on September 30, 2019 over the exercise price of the underlying options.
|
(b)
|
We repurchased 1.0 million shares owned directly or indirectly by our former Chief Executive Officer, including 649,649 outstanding shares and 800,000 vested stock options with a net share equivalent of 350,351 shares, for an aggregate purchase price of $21.4 million.
|
|
2019
|
|
2018
|
|
2017
|
||||||
Total intrinsic value of stock options exercised (in millions)
|
$
|
0.1
|
|
|
$
|
0.1
|
|
|
$
|
3.6
|
|
|
Number of Shares
Underlying Restricted Units — Performance-Based Awards |
|
Number of Shares
Underlying Restricted Units — Time-Based Awards |
||
Outstanding at September 30, 2016
|
4,224,488
|
|
|
5,884,023
|
|
Granted
|
3,224,696
|
|
|
8,457,761
|
|
Earned/released
|
(1,790,514
|
)
|
|
(7,150,783
|
)
|
Forfeited
|
(614,739
|
)
|
|
(713,837
|
)
|
Outstanding at September 30, 2017
|
5,043,931
|
|
|
6,477,164
|
|
Granted
|
2,175,537
|
|
|
8,876,712
|
|
Earned/released
|
(2,092,862
|
)
|
|
(7,156,468
|
)
|
Forfeited
|
(2,087,038
|
)
|
|
(1,325,321
|
)
|
Outstanding at September 30, 2018
|
3,039,568
|
|
|
6,872,087
|
|
Granted
|
1,342,836
|
|
|
9,500,077
|
|
Earned/released
|
(1,405,485
|
)
|
|
(6,383,908
|
)
|
Modification(a)
|
(296,759
|
)
|
|
296,759
|
|
Forfeited
|
(688,835
|
)
|
|
(1,286,071
|
)
|
Outstanding at September 30, 2019
|
1,991,325
|
|
|
8,998,944
|
|
Weighted average remaining recognition period of outstanding Restricted Units
|
1.4 years
|
|
|
1.9 years
|
|
Unrecognized stock-based compensation expense of outstanding Restricted Units
|
$24.5 million
|
|
$84.0 million
|
||
Aggregate intrinsic value of outstanding Restricted Units(b)
|
$32.5 million
|
|
$146.9 million
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted-average grant-date fair value per share
|
$
|
16.52
|
|
|
$
|
15.47
|
|
|
$
|
16.31
|
|
Total intrinsic value of shares vested (in millions)
|
$
|
125.2
|
|
|
$
|
146.5
|
|
|
$
|
146.0
|
|
|
2019
|
|
Dividend yield
|
0.0
|
%
|
Expected volatility
|
27.3% - 30.9%
|
|
Risk-free interest rate
|
2.2% - 3.0%
|
|
Expected term (in years)
|
1 - 3
|
|
|
Number of
Shares
Underlying
Restricted Stock
|
|
Weighted
Average Grant
Date Fair
Value
|
|||
Outstanding at September 30, 2016
|
—
|
|
|
—
|
|
|
Granted
|
250,000
|
|
|
$
|
15.55
|
|
Vested
|
(250,000
|
)
|
|
$
|
15.55
|
|
Outstanding at September 30, 2017
|
—
|
|
|
—
|
|
|
Outstanding at September 30, 2018
|
—
|
|
|
—
|
|
|
Outstanding at September 30, 2019
|
—
|
|
|
—
|
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted-average grant-date fair value per share
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
15.55
|
|
Total intrinsic value of shares vested (in millions)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3.9
|
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted-average grant-date fair value per share
|
$
|
3.76
|
|
|
$
|
4.00
|
|
|
$
|
3.84
|
|
Total shares issued (in millions)
|
1.2
|
|
|
1.3
|
|
|
1.3
|
|
|||
Total stock-based compensation expense (in millions)
|
$
|
4.5
|
|
|
$
|
5.2
|
|
|
$
|
4.9
|
|
|
2019
|
|
2018
|
|
2017
|
|||
Dividend yield
|
0.0
|
%
|
|
0.0
|
%
|
|
0.0
|
%
|
Expected volatility
|
27.8
|
%
|
|
32.1
|
%
|
|
29.3
|
%
|
Risk-free interest rate
|
2.2
|
%
|
|
2.0
|
%
|
|
0.9
|
%
|
Expected term (in years)
|
0.5
|
|
|
0.5
|
|
|
0.5
|
|
Year Ending September 30,
|
|
Operating Leases
|
|
Operating leases under restructuring
|
|
Total
|
||||||
2020
|
|
$
|
34,279
|
|
|
$
|
4,968
|
|
|
$
|
39,247
|
|
2021
|
|
28,740
|
|
|
2,470
|
|
|
31,210
|
|
|||
2022
|
|
23,357
|
|
|
2,170
|
|
|
25,527
|
|
|||
2023
|
|
16,289
|
|
|
2,222
|
|
|
18,511
|
|
|||
2024
|
|
13,209
|
|
|
1,629
|
|
|
14,838
|
|
|||
Thereafter
|
|
48,259
|
|
|
3,189
|
|
|
51,448
|
|
|||
Total
|
|
$
|
164,133
|
|
|
$
|
16,648
|
|
|
$
|
180,781
|
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Domestic
|
$
|
(15,102
|
)
|
|
$
|
(198,525
|
)
|
|
$
|
(245,636
|
)
|
Foreign
|
40,846
|
|
|
(48,699
|
)
|
|
90,966
|
|
|||
Income (loss) before income taxes
|
$
|
25,744
|
|
|
$
|
(247,224
|
)
|
|
$
|
(154,670
|
)
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Current:
|
|
|
|
|
|
|
|
|
|||
Federal
|
$
|
11,294
|
|
|
$
|
1,542
|
|
|
$
|
(5,856
|
)
|
State
|
1,020
|
|
|
(198
|
)
|
|
1,105
|
|
|||
Foreign
|
22,855
|
|
|
23,177
|
|
|
23,196
|
|
|||
Total current
|
35,169
|
|
|
24,521
|
|
|
18,445
|
|
|||
Deferred:
|
|
|
|
|
|
|
|
|
|||
Federal
|
(10,931
|
)
|
|
(83,319
|
)
|
|
7,291
|
|
|||
State
|
1,477
|
|
|
2,302
|
|
|
1,133
|
|
|||
Foreign
|
(114,309
|
)
|
|
(5,824
|
)
|
|
(3,198
|
)
|
|||
Total deferred
|
(123,763
|
)
|
|
(86,841
|
)
|
|
5,226
|
|
|||
(Benefit) provision for income taxes
|
$
|
(88,594
|
)
|
|
$
|
(62,320
|
)
|
|
$
|
23,671
|
|
Effective income tax rate
|
(344.1
|
)%
|
|
25.2
|
%
|
|
(15.3
|
)%
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Federal tax provision (benefit) at statutory rate
|
$
|
5,407
|
|
|
$
|
(60,647
|
)
|
|
$
|
(54,138
|
)
|
State tax provision, net of federal benefit
|
2,175
|
|
|
1,096
|
|
|
1,858
|
|
|||
Foreign tax rate and other foreign related tax items
|
(1,341
|
)
|
|
(10,695
|
)
|
|
(15,768
|
)
|
|||
Stock-based compensation
|
3,368
|
|
|
3,290
|
|
|
6,934
|
|
|||
Non-deductible expenditures
|
8,389
|
|
|
2,375
|
|
|
3,086
|
|
|||
Change in U.S. and foreign valuation allowance
|
168,726
|
|
|
56,557
|
|
|
72,318
|
|
|||
Capital losses
|
(187,822
|
)
|
|
—
|
|
|
—
|
|
|||
Intangible property transfers
|
(171,040
|
)
|
|
—
|
|
|
—
|
|
|||
Uncertain tax positions
|
61,339
|
|
|
4,782
|
|
|
3,111
|
|
|||
Global intangible low-taxed income
|
7,460
|
|
|
—
|
|
|
—
|
|
|||
Base erosion and anti-abuse tax
|
11,216
|
|
|
—
|
|
|
—
|
|
|||
TCJA impact
|
—
|
|
|
(87,058
|
)
|
|
—
|
|
|||
Goodwill impairment
|
—
|
|
|
28,640
|
|
|
—
|
|
|||
Executive compensation
|
1,662
|
|
|
503
|
|
|
5,492
|
|
|||
Other
|
1,867
|
|
|
(1,163
|
)
|
|
778
|
|
|||
(Benefit) provision for income taxes
|
$
|
(88,594
|
)
|
|
$
|
(62,320
|
)
|
|
$
|
23,671
|
|
|
September 30, 2019
|
|
September 30, 2018
|
||||
Deferred tax assets:
|
|
|
|
|
|
||
Net operating loss carryforwards
|
$
|
166,224
|
|
|
$
|
192,017
|
|
Capital loss carryforwards
|
188,320
|
|
|
—
|
|
||
Federal and state credit carryforwards
|
43,897
|
|
|
46,721
|
|
||
Accrued expenses and other reserves
|
33,150
|
|
|
41,371
|
|
||
Difference in timing of revenue related items
|
24,832
|
|
|
81,647
|
|
||
Deferred compensation
|
22,917
|
|
|
19,315
|
|
||
Other
|
11,579
|
|
|
13,802
|
|
||
Total deferred tax assets
|
490,919
|
|
|
394,873
|
|
||
Valuation allowance for deferred tax assets
|
(303,378
|
)
|
|
(183,295
|
)
|
||
Net deferred tax assets
|
187,541
|
|
|
211,578
|
|
||
Deferred tax liabilities:
|
|
|
|
|
|
||
Depreciation
|
(16,833
|
)
|
|
(15,729
|
)
|
||
Convertible debt
|
(87,046
|
)
|
|
(92,452
|
)
|
||
Acquired intangibles
|
(7,517
|
)
|
|
(131,959
|
)
|
||
Net deferred tax liabilities
|
$
|
76,145
|
|
|
$
|
(28,562
|
)
|
Reported as:
|
|
|
|
|
|
||
Other assets
|
$
|
130,361
|
|
|
$
|
21,369
|
|
Long-term deferred tax liabilities
|
(54,216
|
)
|
|
(49,931
|
)
|
||
Net deferred tax liabilities
|
$
|
76,145
|
|
|
$
|
(28,562
|
)
|
|
Year Ended September 30,
|
||||||
|
2019
|
|
2018
|
||||
Balance at the beginning of the year
|
$
|
29,456
|
|
|
$
|
33,245
|
|
Increases related to tax positions from prior fiscal years
|
—
|
|
|
1,590
|
|
||
Decreases related to tax positions from prior fiscal years
|
—
|
|
|
(2,281
|
)
|
||
Increases for tax positions taken during current period
|
60,225
|
|
|
1,709
|
|
||
Decreases for tax settlements and lapse in statutes
|
(1,803
|
)
|
|
(4,083
|
)
|
||
Cumulative translation adjustments
|
(2,291
|
)
|
|
(724
|
)
|
||
Balance at the end of the year
|
$
|
85,587
|
|
|
$
|
29,456
|
|
•
|
The Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement.
|
•
|
The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels.
|
•
|
The Automotive segment is primarily engaged in providing automotive manufacturers and their suppliers branded and personalized virtual assistants and connected car services built on our voice recognition and natural language understanding technologies. As more fully disclosed in Note 4, on November 19, 2018, we announced our intent to spin off our Automotive business into an independent publicly traded company through a pro rata distribution to our common stockholders. On August 5, 2019, we further announced our plans to brand the Automotive spin-off as Cerence and the spin-off was completed on October 1, 2019.
|
•
|
The Other segment includes our SRS and Devices businesses. Our SRS business provides value-added services to mobile operators in India and Brazil (“Mobile Operator Services”) and voicemail transcription services to mobile operators in the rest of the world (“Voicemail-to-Text”). Our Devices business provides speech recognition solutions and predictive text technologies for handset devices. Our Devices revenue has been declining due to the ongoing consolidation of our handset manufacturer customer base and continued erosion of our penetration of the remaining market. During the fourth quarter of fiscal 2018, in connection with our comprehensive portfolio and business review efforts, we commenced a wind-down of our Devices and Mobile Operator Services businesses. In May 2019, we completed the sale of our Mobile Operator Services business in Brazil, and in July 2019, we completed the sale of our Mobile Operator Services business in India. The sale prices and any gain or loss were immaterial to our consolidated financial statement.
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
Segment revenues:
|
(ASC 606)
|
|
(ASC 605)
|
|
(ASC 605)
|
||||||
Healthcare
|
$
|
950,593
|
|
|
$
|
984,819
|
|
|
$
|
899,341
|
|
Enterprise
|
510,753
|
|
|
483,194
|
|
|
474,317
|
|
|||
Automotive
|
306,580
|
|
|
279,402
|
|
|
252,218
|
|
|||
Other
|
61,461
|
|
|
109,064
|
|
|
133,766
|
|
|||
Total segment revenues
|
1,829,387
|
|
|
1,856,479
|
|
|
1,759,642
|
|
|||
Acquisition related revenue adjustments (a)
|
(6,295
|
)
|
|
(14,181
|
)
|
|
(31,467
|
)
|
|||
Total consolidated revenue
|
1,823,092
|
|
|
1,842,298
|
|
|
1,728,175
|
|
|||
Segment profit:
|
|
|
|
|
|
|
|
|
|||
Healthcare
|
337,471
|
|
|
326,658
|
|
|
257,825
|
|
|||
Enterprise
|
141,479
|
|
|
140,478
|
|
|
133,913
|
|
|||
Automotive
|
110,559
|
|
|
109,111
|
|
|
118,248
|
|
|||
Other
|
23,413
|
|
|
28,013
|
|
|
41,186
|
|
|||
Total segment profit
|
612,922
|
|
|
604,260
|
|
|
551,172
|
|
|||
Corporate expenses and other, net
|
(139,806
|
)
|
|
(195,704
|
)
|
|
(121,935
|
)
|
|||
Acquisition-related revenues and costs of revenues adjustment
|
(6,295
|
)
|
|
(14,181
|
)
|
|
(31,467
|
)
|
|||
Stock-based compensation
|
(141,212
|
)
|
|
(142,909
|
)
|
|
(142,901
|
)
|
|||
Amortization of intangible assets
|
(103,563
|
)
|
|
(124,883
|
)
|
|
(150,731
|
)
|
|||
Acquisition-related costs, net
|
(8,909
|
)
|
|
(16,093
|
)
|
|
(27,708
|
)
|
|||
Restructuring and other charges, net
|
(80,465
|
)
|
|
(57,026
|
)
|
|
(59,923
|
)
|
|||
Impairment of goodwill and other intangible assets
|
—
|
|
|
(170,941
|
)
|
|
—
|
|
|||
Other expenses, net
|
(106,928
|
)
|
|
(129,747
|
)
|
|
(171,177
|
)
|
|||
Income (loss) before income taxes
|
$
|
25,744
|
|
|
$
|
(247,224
|
)
|
|
$
|
(154,670
|
)
|
(a)
|
Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.
|
|
Year Ended September 30,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
||||||
United States
|
$
|
1,367,752
|
|
|
$
|
1,374,877
|
|
|
$
|
1,244,900
|
|
International
|
455,340
|
|
|
467,421
|
|
|
483,275
|
|
|||
Total
|
$
|
1,823,092
|
|
|
$
|
1,842,298
|
|
|
$
|
1,728,175
|
|
|
September 30,
2019 |
|
September 30,
2018 |
||||
United States
|
$
|
3,279,186
|
|
|
$
|
3,031,714
|
|
International
|
831,394
|
|
|
982,537
|
|
||
Total
|
$
|
4,110,580
|
|
|
$
|
4,014,251
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Fiscal Year
|
||||||||||
2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenue
|
$
|
493,654
|
|
|
$
|
409,583
|
|
|
$
|
449,197
|
|
|
$
|
470,658
|
|
|
$
|
1,823,092
|
|
Gross profit
|
$
|
280,216
|
|
|
$
|
227,992
|
|
|
$
|
258,506
|
|
|
$
|
276,459
|
|
|
$
|
1,043,173
|
|
Net income (loss) from continuing operations
|
$
|
17,699
|
|
|
$
|
(20,749
|
)
|
|
$
|
9,259
|
|
|
$
|
108,129
|
|
|
$
|
114,338
|
|
Net income (loss) per share - continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
$
|
0.06
|
|
|
$
|
(0.07
|
)
|
|
$
|
0.03
|
|
|
$
|
0.38
|
|
|
$
|
0.40
|
|
Diluted
|
$
|
0.06
|
|
|
$
|
(0.07
|
)
|
|
$
|
0.03
|
|
|
$
|
0.37
|
|
|
$
|
0.39
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
287,796
|
|
|
285,866
|
|
|
285,942
|
|
|
285,754
|
|
|
286,347
|
|
|||||
Diluted
|
292,359
|
|
|
285,866
|
|
|
288,648
|
|
|
291,598
|
|
|
290,125
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Fiscal Year
|
||||||||||
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenue
|
$
|
447,224
|
|
|
$
|
466,193
|
|
|
$
|
449,449
|
|
|
$
|
479,432
|
|
|
$
|
1,842,298
|
|
Gross profit
|
$
|
238,986
|
|
|
$
|
249,173
|
|
|
$
|
248,118
|
|
|
$
|
280,634
|
|
|
$
|
1,016,911
|
|
Net income (loss) from continuing operations
|
$
|
47,465
|
|
|
$
|
(167,141
|
)
|
|
$
|
(20,720
|
)
|
|
$
|
(44,508
|
)
|
|
$
|
(184,904
|
)
|
Net income (loss) per share - continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
$
|
0.16
|
|
|
$
|
(0.57
|
)
|
|
$
|
(0.07
|
)
|
|
$
|
(0.16
|
)
|
|
$
|
(0.63
|
)
|
Diluted
|
$
|
0.16
|
|
|
$
|
(0.57
|
)
|
|
$
|
(0.07
|
)
|
|
$
|
(0.16
|
)
|
|
$
|
(0.63
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
291,367
|
|
|
294,103
|
|
|
292,663
|
|
|
287,052
|
|
|
291,318
|
|
|||||
Diluted
|
295,995
|
|
|
294,103
|
|
|
292,663
|
|
|
287,052
|
|
|
291,318
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
•
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
•
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and,
|
•
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
Item 9B.
|
Other Information
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
Item 11.
|
Executive Compensation
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
Item 14.
|
Principal Accountant Fees and Services
|
Item 15.
|
Exhibits and Financial Statement Schedules
|
(a)
|
The following documents are filed as a part of this Report:
|
(1)
|
Financial Statements — See Index to Financial Statements in Item 8 of this Report.
|
(2)
|
Financial Statement Schedules — All schedules have been omitted as the requested information is inapplicable or the information is presented in the financial statements or related notes included as part of this Report.
|
(3)
|
Exhibits — See Item 15(b) of this Report below.
|
(b)
|
Exhibits.
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed Herewith
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit Index #
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|
2.1
|
|
|
8-K
|
|
001-36056
|
|
2.1
|
|
10/2/2019
|
|
|
|
3.1
|
|
|
10-Q
|
|
0-27038
|
|
3.2
|
|
5/11/2001
|
|
|
|
3.2
|
|
|
10-Q
|
|
0-27038
|
|
3.1
|
|
8/9/2004
|
|
|
|
3.3
|
|
|
8-K
|
|
0-27038
|
|
3.1
|
|
10/19/2005
|
|
|
|
3.4
|
|
|
S-3
|
|
333-142182
|
|
3.3
|
|
4/18/2007
|
|
|
|
3.5
|
|
|
8-K
|
|
0-27038
|
|
3.2
|
|
8/20/2013
|
|
|
|
3.6
|
|
|
8-K
|
|
001-36056
|
|
3.1
|
|
11/7/2019
|
|
|
|
4.1
|
|
Specimen Common Stock Certificate.
|
|
8-A
|
|
0-27038
|
|
4.1
|
|
12/6/1995
|
|
|
4.2
|
|
|
8-K
|
|
0-27038
|
|
4.1
|
|
10/24/2011
|
|
|
|
4.3
|
|
|
8-K
|
|
001-36056
|
|
4.1
|
|
6/22/2015
|
|
|
|
4.4
|
|
|
8-K
|
|
001-36056
|
|
4.1
|
|
12/7/2015
|
|
|
|
4.5
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.1
|
|
|
10-Q
|
|
001-36056
|
|
10.1
|
|
5/9/2019
|
|
|
|
10.2
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
1/17/2019
|
|
|
|
10.3
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.4
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.5
|
|
|
10-Q
|
|
001-36056
|
|
10.3
|
|
8/9/2018
|
|
|
|
10.6
|
|
|
10-K
|
|
001-36056
|
|
10.9
|
|
11/22/2016
|
|
|
|
10.7
|
|
|
10-Q
|
|
001-36056
|
|
10.2
|
|
8/9/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed Herewith
|
|
|
|
|
Incorporated by Reference
|
||||||||
10.8
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
4/19/2016
|
|
|
|
10.9
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.10
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
9/13/2019
|
|
|
|
10.11
|
|
|
8-K
|
|
001-36056
|
|
10.2
|
|
4/19/2016
|
|
|
|
10.12
|
|
|
10-K
|
|
001-36056
|
|
10.16
|
|
11/20/2018
|
|
|
|
10.13
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
3/22/2018
|
|
|
|
10.14
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
10/2/2019
|
|
|
|
10.15
|
|
|
8-K
|
|
001-36056
|
|
10.2
|
|
10/2/2019
|
|
|
|
10.16
|
|
|
8-K
|
|
001-36056
|
|
10.3
|
|
10/2/2019
|
|
|
|
10.17
|
|
|
8-K
|
|
001-36056
|
|
10.4
|
|
10/2/2019
|
|
|
|
10.18
|
|
|
8-K
|
|
001-36056
|
|
10.5
|
|
10/2/2019
|
|
|
|
21.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
23.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
24.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed Herewith
|
|
|
|
|
Incorporated by Reference
|
||||||||
101
|
|
The following materials from Nuance Communications, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Loss, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
|
|
104
|
|
The cover page of this Annual Report on Form 10-K for the year ended September 30, 2019, formatted in Inline XBRL.
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Denotes management compensation plan or arrangement
|
Item 16.
|
Form 10-K Summary
|
|
NUANCE COMMUNICATIONS, INC.
|
|
|
|
|
|
By:
|
/s/ Mark Benjamin
|
|
|
Mark Benjamin
|
|
|
Chief Executive Officer
|
|
|
/s/ Mark Benjamin
|
Date: 11/26/2019
|
|
Mark Benjamin, Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
/s/ Daniel D. Tempesta
|
Date: 11/26/2019
|
|
Daniel D. Tempesta
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
|
/s/ Arthur Giterman
|
Date: 11/26/2019
|
|
Arthur Giterman
Senior Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)
|
|
|
|
|
|
/s/ Daniel J. Brennan
|
Date: 11/26/2019
|
|
Daniel J. Brennan, Director
|
|
|
|
|
|
/s/ Lloyd A. Carney
|
Date: 11/26/2019
|
|
Lloyd A. Carney, Chairman of the Board
|
|
|
|
|
|
/s/ Thomas D. Ebling
|
Date: 11/26/2019
|
|
Thomas D. Ebling, Director
|
|
|
|
|
|
/s/ Robert J. Finocchio
|
Date: 11/26/2019
|
|
Robert J, Finocchio, Jr., Director
|
|
|
|
|
|
/s/ Laura S. Kaiser
|
Date: 11/26/2019
|
|
Laura S. Kaiser, Director
|
|
|
|
|
|
/s/ Michal Katz
|
Date: 11/26/2019
|
|
Michal Katz, Director
|
|
|
|
|
|
/s/ Mark R. Laret
|
Date: 11/26/2019
|
|
Mark R. Laret, Director
|
|
|
|
|
|
/s/ Sanjay N. Vaswani
|
Date: 11/26/2019
|
|
Sanjay N. Vaswani, Director
|
|
|
|
|
|
|
|
•
|
Dividends. Preferred Stock is entitled to receive dividends out of any legally available assets, when and if declared by the Company’s Board of Directors and prior and in preference to any declaration or payment of any dividend on the Common Stock. In addition, after the first issuance of the Series A Participating Preferred Stock, the Company cannot declare a dividend or make any distribution on the Common Stock unless the Company concurrently declares a dividend on such Series A Participating Preferred Stock. Moreover, the Company cannot pay dividends or make any distribution on the Common Stock as long as dividends payable to the Series A Participating Preferred Stock are in arrears. With respect to the Series B Preferred Stock, the Company cannot declare a dividend or make any distribution on the Common Stock unless full dividends on the Series B Preferred Stock have been paid or declared and the sum sufficient for the payment set apart.
|
|
•
|
Voting Rights. Each share of Series A Participating Preferred Stock entitles its holder to 1,000 votes on all matters submitted to a vote of Company stockholders. In addition, the Series A Participating Preferred Stock and the holders of Common Stock vote together as one class on all matters submitted to a vote of our stockholders. The holders of Series B Preferred Stock are not entitled to vote on any matter (except as provided in Delaware law in connection with amendments to the Charter that, among other things, would alter or change the rights and preferences of the class, in which case each share of Series B Preferred Stock would be entitled to one vote). However, the Series B Preferred Stock is convertible into Common Stock, and as a result, may dilute the voting power of the common stock.
|
|
•
|
Liquidation, Dissolution or Winding Up. The Preferred Stock is entitled to certain liquidation preferences upon the occurrence of a liquidation, dissolution or winding up of the Company. If there are insufficient assets or funds to permit this preferential amount, then the Company’s entire assets and all of our funds legally available for distribution will be distributed ratably among the holders of Preferred Stock. The remaining assets, if any, will be distributed to the holders of Common Stock on a pro rata basis.
|
|
•
|
Preemptive Rights. The Series A Participating Preferred Stock and Series B Preferred Stock do not have any preemptive rights.
|
1.
|
Restricted Stock Units. Pursuant to the Company’s 2000 Stock Plan, as amended from time to time (the “Plan”), a copy of which is attached to this Agreement as Exhibit A, the Company hereby grants to Grantee the number of Restricted Stock Units listed in Item B above on the terms and conditions set forth herein and in the Plan, the terms and conditions of the Plan being hereby incorporated into this Agreement by reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the terms and conditions of the Plan shall prevail. Capitalized terms used and not defined in this Agreement will have the meanings set forth in the Plan.
|
2.
|
Company’s Obligation to Pay. Each Restricted Stock Unit represents the right to receive one share of Common Stock of the Company, par value $0.001 (“Share”) after the Restricted Stock Unit has vested. Unless and until the Restricted Stock Units will have vested in the manner set forth in Section 3, Grantee will have no right to receive the Shares subject to the Restricted Stock Units. Prior to the actual issuance of any Shares subject to the Restricted Stock Units, such Restricted Stock Units will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.
|
3.
|
Vesting. Except as provided in Section 4, and subject to Section 5, the Restricted Stock Units shall vest in accordance with the provisions set forth on Exhibit B, subject to Grantee’s continuing to be an employee, director or consultant of the Company or of an Affiliate (a “Service Provider”) through each vesting date. For the avoidance of doubt, Grantee would no longer be considered a Service Provider if Grantee’s employer ceases to be controlled or majority-owned by the Company, in which case the Restricted Stock Units will be forfeited unless otherwise determined by the Administrator, in its discretion.
|
4.
|
Administrator Discretion. The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested Restricted Stock Units at any time, subject to the terms of the Plan. If so accelerated, such Restricted Stock Units will be considered as having vested as of the date specified by the Administrator.
|
5.
|
Forfeiture upon Termination as Service Provider. If Grantee terminates service as a Service Provider, for any or no reason, prior to vesting, Grantee’s right to acquire Shares pursuant to such unvested Restricted Stock Units awarded by this Agreement will immediately terminate.
|
6.
|
Payment After Vesting. Any Restricted Stock Units that vest in accordance with Sections 3 or 4, or otherwise vest in accordance with the terms of the Plan, will be settled by the Company issuing Shares to Grantee, subject to the provisions of Section 8 below. The settlement of vested Restricted Stock Units will be completed by the issuance of the appropriate number of Shares as soon as practicable after vesting, but in each such case no later than the 15th day of the third month following the end of the Company’s tax year that includes each applicable vesting date.
|
7.
|
Rights as Stockholder. Neither Grantee nor any person claiming under or through Grantee will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Grantee.
|
8.
|
Taxes.
|
a.
|
Responsibility for Taxes. Grantee acknowledges that, regardless of any action taken by the Company or, if different, Grantee’s employer (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to Grantee’s participation in the Plan and legally applicable to Grantee as a result of participation in the Plan (“Tax-Related
|
b.
|
Withholding. Prior to the relevant taxable or tax withholding event, as applicable, Grantee agrees to make arrangements satisfactory to the Company to satisfy all Tax-Related Items. In this regard, Grantee authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy their withholding obligations with regard to all Tax-Related Items by one or a combination of the following:
|
i.
|
withholding from Grantee’s wages or other cash compensation otherwise payable to Grantee by the Company and/or the Employer; and/or
|
ii.
|
requiring Grantee to tender a payment in cash (or the cash equivalent) in an amount equal to the Tax-Related Items to the Company or its designee; and/or
|
iii.
|
withholding from the proceeds from the sale of Shares acquired upon settlement of the Restricted Stock Units, either through a voluntary sale or through a mandatory sale arranged by the Company (on Grantee’s behalf pursuant to this authorization without further consent); and/or
|
iv.
|
withholding in Shares to be issued upon settlement of the Restricted Stock Units, provided, however, that if Grantee is an officer of the Company within the meaning of Section 16 of the Exchange Act, the Company will withhold in Shares to be issued upon settlement of the Restricted Stock Units, unless the use of such withholding method is problematic under applicable tax or securities law or has materially adverse accounting consequences, in which case, the Committee (as constituted to satisfy Rule 16b-3 of the Exchange Act) will determine which of the other withholding methods set out in this Section 8(b) will be used; and/or
|
v.
|
any other method determined by the Company and permitted under applicable laws.
|
c.
|
Section 409A. This Agreement and the Restricted Stock Units granted hereunder are intended to meet the “short-term deferral” exception to the provisions of Section 409A of the Code and U.S. Department of Treasury regulations issued thereunder or to otherwise comply with Section 409A of the Code and the U.S. Department of Treasury regulations and guidance issued thereunder, to the extent applicable. Notwithstanding any provision of the Plan or this Agreement to the contrary, this Agreement and the Restricted Stock Units granted hereunder shall be interpreted and construed consistent with this intent. Notwithstanding the foregoing, the Company and its affiliates shall not be required to assume any increased economic burden in connection therewith. Neither the Company or any of its Affiliates, nor any of their respective directors, officers, managers, employees or advisers shall be liable to Grantee (or any other individual claiming a benefit through Grantee) for any tax, interest, or penalties Grantee might owe as a result of this Agreement and the Restricted Stock Units granted hereunder, or otherwise. Notwithstanding anything to the contrary in the Plan or this Agreement, the Company reserves the right, but is not obligated, to revise this Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Grantee, to comply with Section 409 of the Code or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection with this grant of Restricted Stock Units; provided, however, that the Company makes no representation that this Agreement and the Restricted Stock Units granted hereunder will be exempt from, or will comply with, Section 409A of the Code, and makes no undertakings to preclude Section 409A of the Code from applying to this Agreement and the Restricted Stock Units granted hereunder or to ensure that it complies with Section 409A of the Code.
|
9.
|
Assignment; Binding Effect. Subject to the limitations set forth in this Agreement, this Agreement shall be binding upon and inure to the benefit of the executors, administrators, heirs, legal representatives, and successors of the parties hereto; provided, however, that except to the limited extent that may be provided in Section 6, Grantee may not assign any of Grantee’s rights under this Agreement.
|
10.
|
Damages. Grantee shall be liable to the Company for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Restricted Stock Units which is not in conformity with the provisions of this Agreement.
|
11.
|
Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the Commonwealth of Massachusetts, U.S.A., without regard to conflict of laws principles.
|
12.
|
Notices. Except as provided in Section 21, all notices and other communications under this Agreement shall be in writing. Unless and until Grantee is notified in writing to the contrary, all notices, communications, and documents directed to the Company and related to the Agreement, if not delivered by hand, shall be mailed, addressed as follows:
|
13.
|
Arbitration. Any controversy, dispute, or claim arising out of or relating to this Agreement shall be finally settled and binding arbitration administered by JAMS pursuant to its Employment Arbitration Rules and Procedures and subject to JAMS Policy on Employment Arbitration Minimum Standards of Procedural Fairness. A copy of the current JAMS Employment Arbitration Rules & Procedures are available from Human Resources upon request (including concurrently with your review and execution of this Agreement), online in English and Spanish at http://www.jamsadr.com/rules-employment-arbitration/, or by calling JAMS at 800.352.5267. If the JAMS rules are inconsistent with the terms of this Section 13, the terms of this Section shall govern, unless prohibited by applicable law. Any arbitration shall be before a single arbitrator and shall be held in the jurisdiction where Grantee works for the Company or an Affiliate or last worked for the Company or an Affiliate. Judgment on the arbitrator’s award may be entered in any court having jurisdiction. Grantee expressly agrees to waive any right to pursue or participate in any dispute on behalf of, or as part of, any class, representative or collective action, except to the extent such waiver is expressly prohibited by law. Accordingly, to the extent permitted by law, no dispute by the parties hereto shall be brought, heard or arbitrated as a class or collective action, and no party hereto shall serve as a member of any purported class, representative or collective proceeding, including without limitation pending but not certified class actions. Both the Company and Grantee agree that this Section 13 is enforceable under the Federal Arbitration Act, 9 U.S.C.
|
14.
|
No Rights to Restricted Stock Units, Shares, or Employment. Other than with respect to the Restricted Stock Units granted pursuant to, and subject to, this Agreement, neither Grantee nor any other person shall have any claim or right to be issued Shares. Having received a grant of Restricted Stock Units under the Plan shall not give Grantee any right to receive any other grant under the Plan. This grant of Restricted Stock Units is not an employment contract and nothing in this grant of Restricted Stock Units shall be deemed to create in any way whatsoever any obligation on Grantee’s part to continue in the employ or service of the Company or an Affiliate (as applicable) or the Company or an Affiliate (as applicable) to continue Grantee’s employment or service relationship.
|
15.
|
Entire Agreement; Modifications. The Company and Grantee agree that this Agreement is the complete and exclusive statement between the Company and Grantee regarding its subject matter and supersedes all prior proposals, communications, and agreements of the parties, whether oral or written, regarding the grant Restricted Stock Units to Grantee. Grantee expressly warrants that he or she is not accepting this Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. This grant of Restricted Stock Units and any Shares subject to the Restricted Stock Units, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments.
|
16.
|
Additional Conditions to Issuance of Shares. If at any time the Company will determine, in its discretion, that the listing, registration or qualification of the Shares upon any securities exchange or under any law (including any U.S. federal or state or any non-U.S. law), or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Grantee, such issuance will not occur unless and until such listing, registration, qualification, consent or approval will have been effected or obtained free of any conditions not acceptable to the Company.
|
17.
|
Administrator Authority. The Administrator will have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Restricted Stock Units have vested). All actions taken and all interpretations and determinations made by the
|
18.
|
Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
|
19.
|
Agreement Severable. In the event that any provision in this Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Agreement.
|
20.
|
Language. Grantee acknowledges and represents that Grantee is sufficiently proficient in the English language or has consulted with an advisor who is sufficiently proficient in English as to allow Grantee to understand the terms and conditions of this Agreement and any other documents related to the Plan. If Grantee has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different from the English version, the English version will control.
|
21.
|
Electronic Delivery and Participation. The Company may, in its sole discretion, deliver any documents related to this Agreement or to participation in the Plan or to future awards that may be granted under the Plan by electronic means or to request Grantee’s consent to participate in the Plan by electronic means. Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.
|
22.
|
Insider Trading Restrictions/Market Abuse Laws. Grantee acknowledges that he or she may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions including, but not limited to, the United States and Grantee’s country of residence, which may affect Grantee’s ability to directly or indirectly acquire, sell or attempt to sell Shares or rights to Shares (e.g., Restricted Stock Units) under the Plan during such times as Grantee is considered to have “insider information” regarding the Company (as defined by the laws in the applicable jurisdictions). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company. Grantee is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter.
|
23.
|
Non-U.S. and Country-Specific Provisions. The Restricted Stock Units and any Shares subject to the Restricted Stock Units shall be subject to any special terms and conditions set forth in Exhibit C to this Agreement. Moreover, if Grantee relocates to one of the countries included in Exhibit C, the special terms and conditions for such country will apply to Grantee, to the extent the Company determines that the application of such terms and
|
24.
|
Imposition of Other Requirements. The Company reserves the right to impose other requirements on Grantee’s participation in the Plan, on the Restricted Stock Units and on any Shares subject to the Restricted Stock Units, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Grantee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
|
25.
|
Waiver. Grantee acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Grantee or any other grantee.
|
Exhibit A
|
2000 Stock Plan (as Amended and Restated January 17, 2019)
|
Exhibit B
|
Vesting Schedule
|
Exhibit C
|
Non-U.S. and Country-Specific Provisions
|
•
|
the Grantee agrees that any Employer’s Liability that may arise in connection with or pursuant to the vesting of the RSUs (or any restricted stock units granted to the Grantee under the Plan) or the acquisition of Shares or other taxable events in connection with the RSUs (or any other restricted stock units granted under the Plan) will be transferred to the Grantee;
|
•
|
the Grantee authorises the Company and/or the Grantee’s employer to recover an amount sufficient to cover this liability by any method set forth in the Restricted Stock Unit Award Agreement and/or the Joint Election; and
|
•
|
the Grantee acknowledges that even if he or she has accepted the Joint Election via the Company’s online procedure, the Company or the Grantee’s employer may still require the Grantee to sign a paper copy of the Joint Election (or a substantially similar form) if the Company determines such is necessary to give effect to the Joint Election.
|
1.
|
PARTIES
|
(A)
|
You, the individual who has gained access to this Election (the “Employee”), who is employed by one of the employing companies listed in the attached schedule (the “Employer”) and who is eligible to receive Restricted Stock Units (“RSUs”) granted by Nuance Communications, Inc. pursuant to the terms and conditions of the Nuance Communications, Inc. 2000 Stock Plan, as amended (the “Plan”), and
|
(B)
|
Nuance Communications, Inc. of 1 Wayside Road, Burlington, Massachusetts 01803, United States (the “Company”), which may grant RSUs under the Plan and is entering into this Form of Election on behalf of the Employer.
|
2.1
|
This Election relates to RSUs granted by the Company to the Employee under the Plan on or after July 1, 2017.
|
i.
|
an amount that counts as employment income of the earner under section 426 ITEPA (restricted securities: charge on certain post-acquisition events);
|
ii.
|
an amount that counts as employment income of the earner under section 438 of ITEPA (convertible securities: charge on certain post-acquisition events); or
|
iii.
|
any gain that is treated as remuneration derived from the earner’s employment by virtue of section 4(4)(a) SSCBA, including without limitation:
|
(C)
|
the receipt of a benefit in connection with the RSUs, other than a benefit within (i) or (ii) above (within the meaning of section 477(3)(c) of ITEPA).
|
2.3
|
This Election relates to the Employer’s secondary Class 1 National Insurance Contributions (the “Employer’s Liability”) which may arise in respect of the Relevant Employment Income in respect of RSUs pursuant to section 4(4)(a) and/or paragraph 3B(1A) of Schedule 1 of the SSCBA.
|
2.4
|
This Election does not apply in relation to any liability, or any part of any liability, arising as a result of regulations being given retrospective effect by virtue of section 4B(2) of either the SSCBA or the Social Security Contributions and Benefits (Northern Ireland) Act 1992.
|
2.5
|
This Election does not apply to the extent that it relates to relevant employment income which is employment income of the earner by virtue of Chapter 3A of Part VII of ITEPA (employment income: securities with artificially depressed market value).
|
2.6
|
Any reference to the Company and/or the Employer shall include that entity’s successors in title and assigns as permitted in accordance with the terms of the Plan and the Restricted Stock Unit Agreement. This Election will have effect in respect of the RSUs and any awards which replace or replaced the RSUs following their grant in circumstances where section 483 of ITEPA applies.
|
4.1
|
The Employee hereby authorises the Company and/or the Employer to collect the Employer’s Liability in respect of any Relevant Employment Income from the Employee at any time after the Taxable Event:
|
(i)
|
by deduction from salary or any other payment payable to the Employee at any time on or after the date of the Taxable Event; and/or
|
(ii)
|
directly from the Employee by payment in cash or cleared funds; and/or
|
(iii)
|
by arranging, on behalf of the Employee, for the sale of some of the securities which the Employee is entitled to receive in respect of the RSUs; and/or
|
(iv)
|
by any other means specified in the Restricted Stock Unit Agreement.
|
4.2
|
The Company hereby reserves for itself and the Employer the right to withhold the transfer of any securities in respect of the RSUs to the Employee until full payment of the Employer’s Liability is received.
|
4.3
|
The Company agrees to procure the remittance by the Employer of the Employer’s Liability to HM Revenue and Customs on behalf of the Employee within 14 days after the end of the UK tax month during which the Taxable Event occurs (or within 17 days after the end of the UK tax month during which the Taxable Event occurs, if payments are made electronically).
|
5.1
|
The Employee and the Company agree to be bound by the terms of this Election regardless of whether the Employee is transferred abroad or is not employed by the Employer on the date on which the Employer’s Liability becomes due.
|
(i)
|
the Employee and the Company agree in writing that it should cease to have effect;
|
(ii)
|
on the date the Company serves written notice on the Employee terminating its effect;
|
(iii)
|
on the date HM Revenue and Customs withdraws approval of this Election; or
|
(iv)
|
after due payment of the Employer’s Liability in respect of the entirety of the RSUs to which this Election relates or could relate, such that the Election ceases to have effect in accordance with its terms.
|
Registered Office:
|
Wethered House
Pound Lane
Marlow Buckinghamshire
SL7 2AF UK
|
Company Registration Number:
|
4090152
|
Corporation Tax Reference:
|
2015201381
|
PAYE Reference:
|
120VZ29530
|
Registered Office:
|
Wethered House
Pound Lane
Marlow Buckinghamshire
SL7 2AF UK
|
Company Registration Number:
|
4825183
|
Corporation Tax Reference:
|
7347505990
|
PAYE Reference:
|
951/JZ55285
|
Registered Office:
|
1 Pound Lane, Marlow, Buckinghamshire, England, SL7 2AF
|
Company Registration Number:
|
1792924
|
Corporation Tax Reference:
|
2506004151
|
PAYE Reference:
|
577/RM123
|
(A)
|
Name of Grantee:
|
|
|
(B)
|
Number of Restricted Stock Units:
|
|
|
(C)
|
Grant Date:
|
|
|
(D)
|
Vesting Commencement Date:
|
|
|
(E)
|
Award Number:
|
|
|
1.
|
Restricted Stock Units. Pursuant to the Company’s 2000 Stock Plan, as amended from time to time (the “Plan”), a copy of which is attached to this Agreement as Exhibit A, the Company hereby grants to Grantee the number of Restricted Stock Units listed in Item B above on the terms and conditions set forth herein and in the Plan, the terms and conditions of the Plan being hereby incorporated into this Agreement by reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Agreement, the terms and conditions of the Plan shall prevail. Capitalized terms used and not defined in this Agreement will have the meanings set forth in the Plan.
|
2.
|
Company’s Obligation to Pay. Each Restricted Stock Unit represents the right to receive one share of Common Stock of the Company, par value $0.001 (“Share”) after the Restricted Stock Unit has vested. Unless and until the Restricted Stock Units will have vested in the manner set forth in Section 3, Grantee will have no right to receive the Shares subject to the Restricted Stock Units. Prior to the actual issuance of any Shares subject to the Restricted Stock Units, such Restricted Stock Units will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.
|
3.
|
Vesting. Subject to Section 5, the Restricted Stock Units shall vest in accordance with the provisions set forth on Exhibit B, subject to Grantee’s continuing to be an employee, director or consultant of the Company or of an Affiliate (a “Service Provider”) through each vesting date. For the avoidance of doubt, Grantee would no longer be considered a Service Provider
|
4.
|
Forfeiture upon Termination as Service Provider. If Grantee terminates service as a Service Provider, for any or no reason, prior to vesting, Grantee’s right to acquire Shares pursuant to such unvested Restricted Stock Units awarded by this Agreement will immediately terminate.
|
5.
|
Payment After Vesting. Any Restricted Stock Units that vest in accordance with Section 3, or otherwise vest in accordance with the terms of the Plan, will be settled by the Company issuing Shares to Grantee, subject to the provisions of Section 7 below. The settlement of vested Restricted Stock Units will be completed by the issuance of the appropriate number of Shares as soon as practicable after vesting, but in each such case no later than the 15th day of the third month following the end of the Company’s tax year that includes each applicable vesting date.
|
6.
|
Rights as Stockholder. Neither Grantee nor any person claiming under or through Grantee will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Grantee.
|
7.
|
Taxes.
|
a.
|
Responsibility for Taxes. Grantee acknowledges that, regardless of any action taken by the Company or, if different, Grantee’s employer (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to Grantee’s participation in the Plan and legally applicable to Grantee as a result of participation in the Plan (“Tax-Related Items”) is and remains Grantee’s responsibility and may exceed the amount (if any) withheld by the Company or the Employer. Grantee further acknowledges that Company and the Employer (i) make no representations or undertakings regarding the treatment of any
|
b.
|
Withholding. Prior to the relevant taxable or tax withholding event, as applicable, Grantee agrees to make arrangements satisfactory to the Company to satisfy all Tax-Related Items. In this regard, Grantee authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy their withholding obligations with regard to all Tax-Related Items by one or a combination of the following:
|
i.
|
withholding from Grantee’s wages or other cash compensation otherwise payable to Grantee by the Company and/or the Employer; and/or
|
ii.
|
requiring Grantee to tender a payment in cash (or the cash equivalent) in an amount equal to the Tax-Related Items to the Company or its designee; and/or
|
iii.
|
withholding from the proceeds from the sale of Shares acquired upon settlement of the Restricted Stock Units, either through a voluntary sale or through a mandatory sale arranged by the Company (on Grantee’s behalf pursuant to this authorization without further consent); and/or
|
iv.
|
withholding in Shares to be issued upon settlement of the Restricted Stock Units, provided, however, that if Grantee is an officer of the Company within the meaning of Section 16 of the Exchange Act, the Company will withhold in Shares to be issued upon settlement of the Restricted Stock Units, unless the use of such withholding method is problematic under applicable tax or securities law or has materially adverse accounting consequences, in which case, the Committee (as constituted to satisfy Rule 16b-3 of the Exchange Act) will determine which of the other withholding methods set out in this Section 8(b) will be used; and/or
|
v.
|
any other method determined by the Company and permitted under applicable laws.
|
c.
|
Section 409A. This Agreement and the Restricted Stock Units granted hereunder are intended to meet the “short-term deferral” exception to the provisions of Section 409A of the Code and U.S. Department of Treasury regulations issued thereunder or to otherwise comply with Section 409A of the Code and the U.S. Department of Treasury regulations and guidance issued thereunder, to the extent applicable. Notwithstanding any provision of the Plan or this Agreement to the contrary, this Agreement and the Restricted Stock Units granted hereunder shall be interpreted and construed consistent with this intent. Notwithstanding the foregoing, the Company and its affiliates shall not be required to assume any increased economic burden in connection therewith. Neither the Company or any of its Affiliates, nor any of their respective directors, officers, managers, employees or advisers shall be liable to Grantee (or any other individual claiming a benefit through Grantee) for any tax, interest, or penalties Grantee might owe as a result of this Agreement and the Restricted Stock Units granted hereunder, or otherwise. Notwithstanding anything to the contrary in the Plan or this Agreement, the Company reserves the right, but is not obligated, to revise this Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Grantee, to comply with Section 409A of the Code or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection with this grant of Restricted Stock Units; provided, however, that the Company makes no representation that this Agreement and the Restricted Stock Units granted hereunder will be exempt from, or will comply with, Section 409A of the Code, and makes no undertakings to preclude Section 409A of the Code from applying to this Agreement and the Restricted Stock Units granted hereunder or to ensure that it complies with Section 409A of the Code.
|
8.
|
Assignment; Binding Effect. Subject to the limitations set forth in this Agreement, this Agreement shall be binding upon and inure to the benefit of the executors, administrators, heirs, legal representatives, and successors of the parties hereto; provided, however, that except to the limited extent that may be provided in Section 5, Grantee may not assign any of Grantee’s rights under this Agreement.
|
9.
|
Damages. Grantee shall be liable to the Company for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Restricted Stock Units which is not in conformity with the provisions of this Agreement.
|
10.
|
Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the Commonwealth of Massachusetts, U.S.A., without regard to conflict of laws principles.
|
11.
|
Notices. Except as provided in Section 20, all notices and other communications under this Agreement shall be in writing. Unless and until Grantee is notified in writing to the contrary, all notices, communications, and documents directed to the Company and related to the Agreement, if not delivered by hand, shall be mailed, addressed as follows:
|
12.
|
Arbitration. Any controversy, dispute, or claim arising out of or relating to this Agreement shall be finally settled and binding arbitration administered by JAMS pursuant to its Employment Arbitration Rules and Procedures and subject to JAMS Policy on Employment Arbitration Minimum Standards of Procedural Fairness. A copy of the current JAMS Employment Arbitration Rules & Procedures are available from Human Resources upon request (including concurrently with Grantee’s review and execution of this Agreement), online in English and Spanish at http://www.jamsadr.com/rules-employment-arbitration/, or by calling JAMS at 800.352.5267. If the JAMS rules are inconsistent with the terms of this Section 12, the terms of this Section shall govern, unless prohibited by applicable law. Any arbitration shall be before a single arbitrator and shall be held in the jurisdiction where Grantee works for the Company or an Affiliate or last worked for the Company or an Affiliate. Judgment on the arbitrator’s award may be entered in any court having jurisdiction. Grantee expressly agrees to waive any right to pursue or participate in any dispute on behalf of, or as part of, any class, representative or collective action, except to the extent such waiver is expressly prohibited by law. Accordingly, to the extent permitted by law, no dispute by the parties hereto shall be brought, heard or arbitrated as a class or collective action, and no party hereto shall serve as a member of any purported class, representative or collective proceeding, including without limitation pending but not certified class actions. Both the Company and Grantee agree that this Section 12 is enforceable under the Federal Arbitration Act, 9 U.S.C. § 1 et seq. (the “FAA”), and that if the FAA is found not to apply, then this Section 12 is enforceable under the laws of the state in which Grantee is employed at the time Grantee receives this Agreement.
|
13.
|
No Rights to Restricted Stock Units, Shares, or Employment. Other than with respect to the Restricted Stock Units granted pursuant to, and subject to, this Agreement, neither Grantee nor any other person shall have any claim or right to be issued Shares. Having received a grant of Restricted Stock Units under the Plan shall not give Grantee any right to receive any other grant under the Plan. This grant of Restricted Stock Units is not an employment contract and nothing in this grant of Restricted Stock Units shall be deemed to create in any way whatsoever any obligation on Grantee’s part to continue in the employ or service of the Company, or an Affiliate (as applicable) or the Company or an Affiliate (as applicable) to continue Grantee’s employment or service relationship.
|
14.
|
Entire Agreement; Modifications. The Company and Grantee agree that this Agreement is the complete and exclusive statement between the Company and Grantee regarding its subject matter and supersedes all prior proposals, communications, and agreements of the parties, whether oral or written, regarding the grant Restricted Stock Units to Grantee. Grantee expressly warrants that he or she is not accepting this Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. This grant of Restricted Stock Units and any Shares subject to the Restricted Stock Units, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments.
|
15.
|
Additional Conditions to Issuance of Shares. If at any time the Company will determine, in its discretion, that the listing, registration or qualification of the Shares upon any securities exchange or under any law (including any U.S. federal or state or any non-U.S. law), or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Grantee, such issuance will not occur unless and until such listing, registration, qualification, consent or approval will have been effected or obtained free of any conditions not acceptable to the Company.
|
16.
|
Administrator Authority. The Administrator will have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Restricted Stock Units have vested). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Grantee, the Company and all other interested persons. No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement.
|
17.
|
Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
|
18.
|
Agreement Severable. In the event that any provision in this Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Agreement.
|
19.
|
Language. If Grantee has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different from the English version, the English version will control.
|
20.
|
Electronic Delivery and Participation. The Company may, in its sole discretion, deliver any documents related to this Agreement or to participation in the Plan or to future awards that may be granted under the Plan by electronic means or to request Grantee’s consent to participate in the Plan by electronic means. Grantee hereby consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.
|
21.
|
Insider Trading Restrictions/Market Abuse Laws. Grantee acknowledges that he or she may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions including, but not limited to, the United States and Grantee’s country of residence, which may affect Grantee’s ability to directly or indirectly acquire, sell or attempt to sell Shares or rights to Shares (e.g., Restricted Stock Units) under the Plan during such times as Grantee is considered to have “insider information” regarding the Company (as defined by the laws in the applicable jurisdictions). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable insider trading policy of the Company. Grantee is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter.
|
22.
|
Non-U.S. and Country-Specific Provisions. The Restricted Stock Units and any Shares subject to the Restricted Stock Units shall be subject to any special terms and conditions set forth in Exhibit C to this Agreement. Moreover, if Grantee relocates to one of the countries included in Exhibit C, the special terms and conditions for such country will apply to Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative purposes. Exhibit C constitutes part of this Agreement.
|
23.
|
Imposition of Other Requirements. The Company reserves the right to impose other requirements on Grantee’s participation in the Plan, on the Restricted Stock Units and on any Shares subject to the Restricted Stock Units, to the extent the Company determines it is
|
24.
|
Waiver. Grantee acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Grantee or any other grantee.
|
Exhibit A
|
2000 Stock Plan (as Amended and Restated January 17, 2019)
|
Exhibit B
|
Vesting Schedule
|
Exhibit C
|
Non-U.S. and Country-Specific Provisions
|
|
|
|
|
|
|
|
|
|
Subsidiary Name
|
|
Jurisdiction
|
|
Type
|
||||
|
|
|
|
|
|
|
|
|
Agnitio Corp.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Caere LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Cerence AI LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Cerence Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Cerence Operating Company
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Cognition Technologies, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
ComplyMD LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Consolidated Enterprise Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Consolidated Healthcare Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Consolidated Imaging Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Consolidated Mobile Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Ditech Networks, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Ditech Networks International, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
eCopy, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
iScribes Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
eScription, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Language and Computing, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Montage Healthcare Solutions, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Nuance Diagnostics Holding, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Nuance Transcription Services, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
PerSay, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Phonetic Systems, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Primordial Design, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Quadramed Quantim Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
SNAPin Software, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
SVOX USA, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
TouchCommerce, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Viecore Federal Systems Division, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
Viecore, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
VirtuOz, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
VoiceBox Technologies LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
J.A. Thomas and Associates, Inc.
|
|
|
Georgia
|
|
|
|
Domestic
|
|
Nuance Healthcare Diagnostics Solutions, Inc.
|
|
|
Georgia
|
|
|
|
Domestic
|
|
Winscribe USA Inc
|
|
|
Illinois
|
|
|
|
Domestic
|
|
New England Medical Transcription, Inc.
|
|
|
Maine
|
|
|
|
Domestic
|
|
AMS Solutions Corporation
|
|
|
Massachusetts
|
|
|
|
Domestic
|
|
Accentus U.S., Inc. f/k/a Zylomed Inc.
|
|
|
Nevada
|
|
|
|
Domestic
|
|
Medical Transcription Education Center, Inc.
|
|
|
Ohio
|
|
|
|
Domestic
|
|
Physician Technology Partners, LLC
|
|
|
Ohio
|
|
|
|
Domestic
|
|
Nuance Enterprise Solutions & Services Corporation f/k/a Varolii Corporation
|
|
|
Washington
|
|
|
|
Domestic
|
|
Information Technologies Australia Pty Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
ITA Services Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
Nuance Communications Australia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
OTE Pty. Limited
|
|
|
Australia
|
|
|
|
International
|
|
VoiceBox Technologies Australia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
Winscribe Australasia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
|
|
|
|
|
|
|
|
Nuance Communications Austria GmbH
|
|
|
Austria
|
|
|
|
International
|
|
Nuance Communications Services Austria GmbH
|
|
|
Austria
|
|
|
|
International
|
|
SpeechMagic Holdings GmbH
|
|
|
Austria
|
|
|
|
International
|
|
Multi-Corp International Ltd.
|
|
|
Barbados
|
|
|
|
International
|
|
Language and Computing N.V.
|
|
|
Belgium
|
|
|
|
International
|
|
Nuance Communications Belgium Limited
|
|
|
Belgium
|
|
|
|
International
|
|
Cerence BVBA
|
|
|
Belgium
|
|
|
|
International
|
|
Nuance Bermuda Automotive, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
Nuance Bermuda Enterprise, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
Nuance Bermuda Healthcare, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
Nuance Communications Ltda.
|
|
|
Brazil
|
|
|
|
International
|
|
Novitech Technologia e Servicos Ltda.
|
|
|
Brazil
|
|
|
|
International
|
|
BlueStar Options Inc.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
BlueStar Resources Ltd.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
SpeechWorks BVI Ltd.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
845162 Alberta Ltd.
|
|
|
Canada
|
|
|
|
International
|
|
Accentus Inc. f/k/a/ 2350111 Ontario Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Cerence Holding Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Ditech Networks Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Cerence Acquisition ULC
|
|
|
Canada
|
|
|
|
International
|
|
Cerence Technologies Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Nuance Communications Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Zi Corporation
|
|
|
Canada
|
|
|
|
International
|
|
Zi Corporation of Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
Foxtrot Acquisition Limited
|
|
|
Cayman Islands
|
|
|
|
International
|
|
Foxtrot Acquisition II Limited
|
|
|
Cayman Islands
|
|
|
|
International
|
|
Huayu Zi Software Technology (Beijing) Co., Ltd.
|
|
|
China
|
|
|
|
International
|
|
Cerence Software Technology (Beijing) Co., Ltd.
|
|
|
China
|
|
|
|
International
|
|
Cerence Comm Tech (Shanghai) Co. Ltd.
|
|
|
China
|
|
|
|
International
|
|
USA Shenyu Technologies (Shenzhen) Co. Ltd.
|
|
|
China
|
|
|
|
International
|
|
Nuance Communications Finland OY
|
|
|
Finland
|
|
|
|
International
|
|
Voice Signal Technologies Europe OY
|
|
|
Finland
|
|
|
|
International
|
|
Nuance Communications France Sarl
|
|
|
France
|
|
|
|
International
|
|
VirtuOz S.A.
|
|
|
France
|
|
|
|
International
|
|
VoiceBox Technologies France SAS
|
|
|
France
|
|
|
|
International
|
|
Cerence GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Nuance Communications GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Nuance Communications Deutschland GmbH f/k/a Dictaphone Deutschland GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Nuance Communications Germany GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Nuance Communications Healthcare Germany GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Cerence Deutschland GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Voicebox Technologies Deutschland GmbH
|
|
|
Germany
|
|
|
|
International
|
|
Asia Translation & Telecommunications Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Huayu Zi Software Technology Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Cerence Hong Kong Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Telecom Technology Corporation Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Zi Corporation (H.K.) Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Zi Corporation of Hong Kong Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
Nuance Communications Hungary Kft
|
|
|
Hungary
|
|
|
|
International
|
|
Ditech Communications India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
Nuance India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
|
|
|
|
|
|
|
|
Nuance Transcription Services India Private Limited f/k/a/ FocusMT India Private Limited
|
|
|
India
|
|
|
|
International
|
|
ServTech Systems India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
Transcend India Private Limited
|
|
|
India
|
|
|
|
International
|
|
Transcend MT Services Private Ltd.
|
|
|
India
|
|
|
|
International
|
|
Cerence Services (India) LLP
|
|
|
India
|
|
|
|
International
|
|
Nuance Communications International Holdings ULC
|
|
|
Ireland
|
|
|
|
International
|
|
Nuance Communications Ireland Limited
|
|
|
Ireland
|
|
|
|
International
|
|
Nuance Communications Services Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
Diamond Auto Technologies Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
Cerence Services Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
Nuance Communications Healthcare International Ltd formally Voice Signal Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
Nuance Communications Israel Ltd.
|
|
|
Israel
|
|
|
|
International
|
|
PerSay Ltd.
|
|
|
Israel
|
|
|
|
International
|
|
Phonetic Systems Ltd.
|
|
|
Israel
|
|
|
|
International
|
|
Cerence s.r.l.
|
|
|
Italy
|
|
|
|
International
|
|
Loquendo S.p.a.
|
|
|
Italy
|
|
|
|
International
|
|
Nuance Communications Italy Srl
|
|
|
Italy
|
|
|
|
International
|
|
Cerence Japan K.K.
|
|
|
Japan
|
|
|
|
International
|
|
Nuance Japan K.K.
|
|
|
Japan
|
|
|
|
International
|
|
Cerence Ltd Korea
|
|
|
Korea
|
|
|
|
Intenational
|
|
Caere Corporation Branch Mexico
|
|
|
Mexico
|
|
|
|
International
|
|
Cerence B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
Cerence Holding B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
Cerence Services B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
Nuance Communications Netherlands B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
X-Solutions Group B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
Winscribe Inc. Ltd.
|
|
|
New Zealand
|
|
|
|
International
|
|
VoiceBox Technologies Europe B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
Heartland Asia (Mauritius) Ltd.
|
|
|
Republic of Mauritius
|
|
|
|
International
|
|
Nuance Communications Asia Pacific Pte. Ltd.
|
|
|
Singapore
|
|
|
|
International
|
|
Nuance Communications Korea Ltd.
|
|
|
South Korea
|
|
|
|
International
|
|
Nuance Communications Iberica SA
|
|
|
Spain
|
|
|
|
International
|
|
Agnitio S.L.
|
|
|
Spain
|
|
|
|
International
|
|
Cerence Operations SL
|
|
|
Spain
|
|
|
|
International
|
|
Cerence A.B.
|
|
|
Sweden
|
|
|
|
International
|
|
Nuance Communications Sweden, A.B.
|
|
|
Sweden
|
|
|
|
International
|
|
Cerence Switzerland AG
|
|
|
Switzerland
|
|
|
|
International
|
|
SVOX AG
|
|
|
Switzerland
|
|
|
|
International
|
|
Winscribe GmbH
|
|
|
Switzerland
|
|
|
|
International
|
|
Cerence Taiwan Ltd.
|
|
|
Taiwan
|
|
|
|
International
|
|
Nuance Communications Illetism Ltd. Sirketi
|
|
|
Turkey
|
|
|
|
International
|
|
Nuance Turkey Iletisim Hizmetleri Ltd. Sirketi
|
|
|
Turkey
|
|
|
|
International
|
|
Ditech Communications Europe Ltd.
|
|
|
United Kingdom
|
|
|
|
International
|
|
Cerence Ltd.
|
|
|
United Kingdom
|
|
|
|
International
|
|
Nuance Communications UK Limited
|
|
|
United Kingdom
|
|
|
|
International
|
|
SpinVox Limited
|
|
|
United Kingdom
|
|
|
|
International
|
|
Winscribe Europe Limited
|
|
|
United Kingdom
|
|
|
|
International
|
|
TouchCommerce UK Ltd.
|
|
|
United Kingdom
|
|
|
|
International
|
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
|
|
By:
|
|
/s/Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
|
By:
|
|
/s/Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|